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By creating antibodies against antigens, B-cells, also named B-lymphocytes, play
an important role in the immune system to fight against foreign invasion to the host body.
Within the antigen specific to a certain B-cell antibody, the sections recognized and
bound by antibody are called B-cell epitopes. As antigenic determinants, B-cell epitope
identification is of vital importance in many immunological processes, such as vaccine
design, immunodiagnostic tests, and antibody production. Towards this goal, biologists
and immunologists have applied a variety of methods to identify B-cell epitopes through
both experiments and bioinformatic predictions. Since the experiments for searching Bcell epitopes are time-consuming and expensive, bioinformatic methodologies have
become important for the high-throughput study of B-cell epitopes.
There are two kinds of B-cell epitopes: linear (continuous) epitopes and
conformational (discontinuous) epitopes. The methodologies and difficulties of
bioinformatic predictions for the two categories are quite different. Due to more
challenges of conformational B-cell epitope prediction, currently most of prediction tools
aim to linear B-cell epitope.

The importance of B-cell epitopes has driven the development of faster and more
precise tools in the past thirty years. Unfortunately, the limited success of these existing
methods cannot match expectation because the achieved specificity and sensitivity leave
room to be desired. In this dissertation, we developed new linear B-cell epitope tool
SVMTriP with a sensitivity of 80.1% and a precision of 55.2%, which is higher than
other tools such as BCPred and AAP (Chapter Two). We also developed new
conformational B-cell prediction tool EPSVR and a meta server EPmeta based on
Support Vector Regression (Chapter Three). Comparing to other conformational B-cell
prediction tools such as DiscoTope, EPSVR shows a better prediction with AUC (Area
Under receiver operating characteristic Curve) of 0.597. In addition, we are working on
the tool SVMKER to predict epitopic residues on antigen (Chapter Four). To our
knowledge, SVMKER is the first epitopic residue prediction tool just using protein
sequence as input. These online tools will provide more choices for the identification of
protein epitope by bioinformatic methodology.
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CHAPTER ONE: THE IMMUNE SYSTEM AND B-CELL EPITOPES
1. Introduction to the Immune System
1.1 Immune system
Our immune system protects us throughout our lives against surrounding
pathogenic factors, such as viruses, bacteria, pathogenic fungi and eukaryotic parasites.
This powerful and profound system can usually be divided into two major categories: the
innate immune system and the adaptive immune system (1). The innate immune system,
also called the non-specific immune system, is the first defense line to fight against the
invaders. The basic components of the innate immune system include barrier epithelial
cells, in vivo sentinel cells for recognition and following removal, and Natural Killer cells
for killing invader. The innate system demonstrates a generic immune response to
varieties of pathogens. Sentinel cells, for example, present so-called pattern recognition
receptors (PRRs) on their surfaces. PRRs recognize pathogen-associated molecular
patterns (PAMPs) presented exclusively on microbe pathogens. Since PAMPs are shared
by different pathogenic sources, the inflammatory responses followed by the recognition
of PAMPs by PRRs are still non-specific (1). Furthermore, the innate immune system
cannot confer memorable and long-lasting immunity to the host.
In contrast to the innate immune system, the adaptive system responds to
pathogens in a completely different manner. During adaptive mechanisms, highly
specialized white blood cells carry on adaptive immune responses to known or unknown
pathogens on the second and third defense lines of the whole immune system. The
adaptive immune system uses a small number of genes to express a large amount of
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different antigen receptors. These receptors are uniquely expressed in different individual
lymphocytes, and the offspring cells of lymphocytes inherit the same receptor specificity.
As a consequence, the immunity acquired by the adaptive immune system can be learned,
memorized, and then kept for long-lasting protection. Therefore, the adaptive immune
system represents a more flexible evolutionary protection strategy against fugitive and
unstable environment than the innate one (2). Among the entire defensive lines of the
immune systems, T- and B-cells play the most important roles to recognize, lock, and
eliminate the potentially harmful invaders. They will are discussed in the next section.
1.2 T-Cell and B-cell
Among immune components, T- and B-cells have been given the most attention
by immunologists. Both T- and B-cells belong to one kind of white blood cells called
lymphocytes, but the immune responses mediated by the two cell types are entirely
different. T-cell immunity is based on cell-mediated attacks against foreign invaders into
the host, while B-cell specifically plays an important role on so-called humoral immunity,
which generates antibodies to search and recognize harmful antigens. Both T- and B-cells
are initiated in bone marrow. However, T-cells are transferred to the thymus before their
maturation, whereas B-cells stay in bone marrow until maturation. After mature T- or Bcells form, they will both immigrate to the bloodstream and be transferred throughout the
host body.
According to their distinct roles, T-cells may be classified into multiple subgroups,
including 1) Helper T-cells, 2) Cytotoxic T-cells, 3) Memory T-cells, and 4) Regulatory
T-cells. Helper T-cells are also called CD4+ T-cells due to the expression of the protein
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CD4 on the surface of mature helper T-cells. By secreting cytokines, helper T-cells
function on the maturation of B-cells, activation of cytotoxic T-cells, and enhancement of
the immune response of macrophages. Cytotoxic T-cells (also called CD8+ T-cells) can
kill infected target T-cells directly, so sometimes they are also called T-killer cells.
Cytotoxic T-cells may also kill tumor cells and even normal cells of a transplanted organ
after surgery. Memory T-cells once experience the antigen-mediated infection, show a
faster and stronger immune response when encountering the cognate antigen at the
second time. The immunological memory comes from the proliferation and
differentiation of naive T-cells undergoing the activation by antigen. 4) Regulatory Tcells (also known as suppressor T-cells) are a subset of specific T-cells involved in
immunological tolerance. Regulatory T-cells suppress immune responses of other T-cells
that can cause tissue damage. They induce tolerance to self-antigens and avoid
autoimmune diseases (3). Despite the different roles of these T-cells, their immune
responses are mediated by the cells themselves. It means that these cells are directly
involved in recognition, binding, and destroying of foreign invaders.
Unlike the direct action of T-Cells, B-cells produce a variety of antibodies to
obtain specific recognition to antigens. These antibodies, also called immunoglobulins,
are a class of secreted proteins with a special Y shape. The Y shape of an antibody is
composed of three components, one containing two C termini of heavy chains and the
other two containing N termini of heavy chains and the whole light chains. Among a
heavy chain, its C terminus is connect to N terminus by a flexible connecting chain
(Figure 1.1). Therefore, the existence of these flexible connection chains can be adaptive
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to the movement of N-terminus of Y shape, and enhance the binding of the light chains
with antigens.

Figure 1.1 The Y shape of an antibody (top) and the 3D structure of the antibody
(down, PDB ID: 1IGT) (4). Commonly, an antibody is composed of two light and two
heavy chains. The flexible chains in the middle of the heavy chains determine the
conformation of the antigen binding site of the antibody.
Although all the antibodies share the same Y shape, they can be categorized into
five classes (IgA, IgD, IgE, IgG, and IgM) due to different C regions that are C terminus
of heavy chain. Each class of antibody has its own in vivo location, acceptor, and specific
biological function (1, 2). For example, IgA is the dominant antibody class in the
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mucosal immune system such as the gut, respiratory tract and urogenital tract. IgA may
prevent pathogen adherence. IgD may function to bind an antigen receptor when a B-cell
meets with an unknown antigen. IgE is an especially interesting subclass of antibodies
because it is mainly involved in allergic response. The interaction of allergen and IgE
triggers the activation of mast T-cells, leading to a series of allergy-related characteristics.
IgE is also found in autoimmune diseases. IgG is the major form in antibody-mediated
immunity. It can search and recognize different antigens by taking different forms. In
addition, IgG is the only antibody class that is transferred from mother to fetus through
the placenta in passive immunity. IgM has a strong binding to pathogens. If there is no
sufficient IgG, IgM may act instead to eliminate pathogens. Together, these five classes
of antibodies can accomplish humoral immunity mediated by B-cells.
Studies on antibodies advance vaccine invention. A given kind of antibody may
uniquely bind to its corresponding antigen. At the same time, the immuno-property of the
antibody can usually be inherited and memorized by the host body as discussed above.
The injection of vaccine (which actually is a „dead‟ or inactive antigen) to the host body
aims at the production of corresponding antibody by the in vivo immune system. The
antibody may be memorized and kept effective against future invasions by the same
active antigen for a period of time. Hence, understanding the interactions between
antigens and antibodies becomes a key step to design novel vaccines against different
kinds of diseases which patients are currently suffering with.
2. Antibody-antigen complex 3D structure
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The most accurate way to study the antibody-antigen interaction is with a 3D
complex structure. Unfortunately, there is a very limited number of antibody-antigen
complex 3D structures in Protein Data Bank (PDB,
http://www.rcsb.org/pdb/home/home.do) (5). For example, for Homo sapiens, there are
only approximately 200 antibody-antigen complex 3D structures available in the PDB as
of May 20th, 2013. To put this in perspective, it has been estimated that humans generate
10 billion different antibodies, therefore forming 10 billion unique interactions with their
corresponding antigens (6). Among the 3D structures, most of them show a roughly
similar appearance due to the special Y shape of the antibody. Using protein structure
4JAN as example (Figure 1.2), we may clearly find that the antigen-binding site of the
antibody is located at the component which contains the entire light chain and a part of
heavy chain. The same binding pattern is also found in other antibodies.
Although it is a kind of protein-protein interaction, antibody-antigen binding
seems quite distinctive from other protein-protein interactions due to the specific roles of
antibodies. First of all, the antibody-antigen complex is categorized as non-obligate
which means the individual antibody and antigen also exist in vivo accompanying the
antibody-antigen complex. Furthermore, this kind of non-obligate antibody-antigen
complex is proven to be transient, which means the affinity between the antibody and the
antigen is also not strong (6). Therefore, considering their specific binding patterns,
antibody-antigen interactions cannot be studied by simply applying regular proteinprotein interaction strategies, especially when trying to develop prediction tools for
antibody-antigen interactions.

7
To investigate antibody-antigen complexes, much attention has been given to the
antibody-binding site of antigens since this small portion of the antigen structure is in
direct charge of binding with the antibody (13). For one thing, the identification of
antibody-binding sites is a relatively easier task in structural biology due to their
decreased sizes compared with the complete antigen proteins. Moreover, epitope
identification is also the most vitally important part in antigen studies for medical
applications, such as immuno-diagnosis and the development of novel vaccines. B-cell
epitopes will be discussed in detail in the next section.

Figure 1.2 Crystal structure of broadly neutralizing antibody CH103 in complex
with HIV-1 gp120 (PDB ID: 4JAN) (8). An antibody binds to the antigen through its
light-heavy overlap chain.

3. B-cell Epitope
3.1 Introduction to B-cell Epitopes
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Epitopes are the antigenic determinants involved in antibody-antigen interactions.
B-cells are commonly found in most mammals. By creating antibodies against antigens,
B-cells play an important role in the immune system to fight against pathogenic invasions.
Among the antigens related to B-cells, the sections recognized and bound by antibodies
are called B-cell epitopes (Figure 1.3). Since they are antigenic determinants, the
identification of B-cell epitopes helps biologists and immunologists investigate the
pathways in the body‟s self-protection systems (9).

Figure 1.3 Epitope is the antibody-binding site on an antigen. The blue region of the
antigen which binds to the antibody is called an epitope.
There are two types of B-cell epitopes. Linear (continuous) epitopes are short
peptides containing a contiguous amino acid sequence, whereas conformational
(discontinuous) epitopes are composed of amino acids that are not contiguous in
sequence but close in the 3D structures (10).Some researchers have the view that the
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boundary between linear and conformational epitopes is vague, because one
conformational epitope may be seen as the combination of more than one shorter linear
epitopes (13). The searching of conformational B-cell epitopes is much more difficult
because the scarcely available 3D structure of an antigen is usually needed. Considering
the complexity of conformational B-cell epitopes, most current research focuses instead
on linear epitopes. The challenges of conformational B-cell epitope predictions will be
discussed in detail in Chapter 3.
3.2 Applications of B-cell Epitopes
The identification of B-cell epitopes can be the foundation for many immunoapplications. For example, with the knowledge of an epitope sequence, we can synthesize
peptides mimicking the epitope for diagnosing human diseases, such as tuberculosis.
Another more exciting application lies in vaccine design. A vaccine is the assumed „dead‟
or inactive form of a disease-caused pathogen, or any item can trigger immune response,
hich is without the original activity or harmful impact on the host body. Vaccines can
trigger the immune system and induce the production of correlated antibodies. For the
host, the appearance of antibodies may be memorized and inherited so that the host body
can be protected against the same „true‟ pathogen for a period, or even the whole lifetime.
Vaccines are widely used for human beings from infancy to adulthood against many
different pathogens and infections. For example, some epidemics which were once fatal
to the world, such as smallpox, have been controlled efficiently due to the invention of
disease-specific vaccines (11, 12). Hence, vaccine design is a medical application of vital
importance, and many more novel vaccines against fatal diseases for public health are
constantly under investigation and testing.
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One key step for vaccine design is the determination of the epitope on an antigen.
With this knowledge, by protein recombinant technologies, we may produce epitopebased vaccines which reduces or eliminates the pathogenic sites of the real antigens.
Hence, the epitope-based vaccines will keep the antigenicity and immunogenicity of the
original antigens due to the presence of the epitopes, but lack the pathogenicity due to the
absence of the active sites. When these epitope-based vaccines are injected into the host
body to induce antibody genesis, they pose the least risk of adverse effects due to the
minimal original antigen structures beyond the epitopes. At the same time, the immunity
is triggered by epitope-based vaccines which then protects the host body against any
future invasion of the same kind of antigen (13). Because of this unique advantage, the
identification of B-cell epitopes is one of the major focuses of research for immunologists.
4. Immunology and immunoinformatics
4.1 Immunology
Immunology focuses on the components, responses, and mechanisms of the
immune systems of all organisms, especially humans and other vertebrates. Its origin may
date back to the 18th century or even earlier. In 1796, Edward Jenner firstly discovered
the induced protection against human smallpox disease by cowpox (14). The induction
procedure was then called vaccination, which continues to be used today. After the first
successful demonstration of vaccination, more and more practical vaccines, such as
rabies vaccine (1885) (15) and influenza vaccine (1945) (16, 17), were found and
approved for public use. In the serum of a vaccinated individual, Emil von Behring and
Shibasaburo Kitasato (1898) for the first time found antibodies, the important substances
specifically binding to corresponding pathogens, which initiated the era with the humoral
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theory of immunity (18). Thereafter, the causes of infectious diseases were gradually
discovered, and the roles of pathogenic sources, such as viruses, bacteria, fungi, and
parasites, were determined as infectious agents. It was accepted that the immune system,
as the in vivo self-protection mechanism, can automatically reduce or even eliminate the
effect of invading pathogens. Due to the important medical relevance, the cells and body
tissues involved in the immune system have been systematically studied since then. By
understanding how the immune system works, immunologists may design clinical
strategies to control the immune responses to both disease-causing pathogens and nonharmful antigens. For example, antihistamine was designed to block histamine binding to
histamine receptors and then inhibit the subsequent inflammatory responses. Hence,
antihistamines may be used for allergy relief and to help patients reduce the pain from
histamine-induced swelling and itching (3). Compared with most other biological
branches, immunology is a rather new field with many immunological pathways and
mechanisms still to be discovered.
The study of immunology is not only challenging but also highly valuable. The
level of complexity in the immune system comes from life itself. The evolution of life
always finds a way so that the immune system keeps developing against the evolution of
the pathogens and their ever-changing invasion strategies. As a consequence, there are
always new topics to investigate when people attempt to uncover the details of the
immune system. The immune system is so complex that immunology is divided into
many individual sub-areas, such as classical immunology, clinical immunology,
developmental immunology, diagnostic immunology, and evolutionary immunology.
Varieties of immune organs or tissues, such as T-cell, B-cell, spleen, thymus, bone
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marrow, and lymph, may be the unique research focuses for individual immunological
research groups. The achievements from these immunological studies can provide
valuable insights and strategies for medical applications. As an example, the influenza
vaccine, a most common immunological application, has saved millions of lives since it
was introduced to the public. In the history of influenza pandemic, influenza viruses, such
as H1N1, H2N2, and H3N2, have taken away numerous human lives. For example, Some
report estimated that spanish flu caused by H1N1 killed at least 50 million people in
1918-1920 (19). Another H1N1 outbreak occurred in 2009 and ~185, 000 people died
worldwide from April 2009 to August 2010. The lower mortality rate despite the more
densely-populated world today was largely due to the invention and the widespread
adoption of influenza vaccines (20). The induced antibody by the influenza vaccine may
reduce the probability of virus infection and better protect us. As a consequence, due to
their direct importance in medical applications, antibodies and their producer B cells are
one major research focus for immunologists.
4.2 Immunoinformatics
The burgeoning immunological data drives a new field in immunology called
immunoinformatics. Immunoinformatics is a branch of bioinformatics that has been
developing quickly in the past decade. Using the principles of bioinformatics and
computational biology, immunoinformatics researchers have begun to manage the
collection, summary, data mining, and convenient Internet sharing of immunological
resources. In addition to creating immune-related databases, a series of novel tools, such
as data analysis, sequence alignments, and biophysical predictions, have been developed
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to solve the questions on immunology. Below I summarize the development of
immunoinformatics databases and prediction tools for B-cell epitopes.
4.2.1 B-cell Epitope Databases
With the growing resources of B-cell epitopes, it is necessary to collect and
organize known information on reported B-cell epitopes with well-designed structures
into databases. At present, there are several databases available online and free for public
access. Some of these databases focus on linear B-cell epitopes, such as Bcipep
(http://www.imtech.res.in/raghava/bcipep/data. html) which contains 2479 known linear
B-cell epitopes (21). Another popular B-cell epitope database is Immune Epitope
Database (IEDB, http://www.iedb. org/) which collects not only linear B-cell epitopes but
also conformational B-cell epitopes and 3D structures of antibody-antigen structures (22).
Actually, IEDB collects much more entries than other B-cell epitope databases. For
example, as of May 30, 2013, there are 63452 B-cell linear epitope entries, 2056
conformational B-cell epitopes entries, and 646 3D structures of antibody-antigen
complexes related to B-cell available in the IEDB database.
The B-cell epitopes collected in the databases above still represent only a small
portion of all antigenic determinants which the immunologists are interested in. There is a
need to search and identify more. There are many ways to determine B-cell epitopes,
including experimental searching strategies and bioinformatic prediction tools based on
biostatistical and bioinformatic technologies. Experimental results are reliable but
conducting such experiments is time- and resource- consuming. Sometimes such
experimental searches could be blind or random, in the hope of identifying something
useful. On the other hand, bioinformatic predictions have the alternative advantages, such
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as fast speed and low cost, comparing to the experiments. Although such predictions
suffer from intrinsic false-positive rates, the quick and high-throughput properties are
highly desirable, allowing researchers to develop novel methods with improved
prediction performance. Even though 100% accuracy cannot be achieved, the predicted
epitopes from bioinformatic methods can greatly narrow down the searching space for
subsequent experiments and validations, and provide reasonable candidates to decrease
the randomness of experimental searches. Therefore, the development of bioinformatic
prediction tools has been a vital part of the study on B-cell epitopes. Linear and
conformational predictions will be reviewed in more detail in the following two sections.
4.2.2 Principles of Linear B-cell Epitope Prediction
The prediction of linear B-cell epitopes is easier than that of conformational
epitopes. Usually, the linear B-cell epitope prediction tool is at the protein-sequence level.
That is, many previous studies on linear B-cell epitope prediction are based on the
physicochemical property (or propensity scale) of constituent amino acids. With the input
of protein sequences, the prediction tools are based upon the amino acid properties
including hydrophilicity (23, 24), solvent accessibility (25), secondary structure (26),
flexibility , and antigenicity (27). These known B-cell linear epitope prediction tools
include but are not limited to: PEOPLE (28), BEPITOPE (29), BepiPred (30), ABCPred
(31), AAP (32), BCPred (33), BayesB (34), BEOracle/BROracle (35), and BEST (36). In
these various prediction tools, different properties of amino acid sequences were applied.
For example, PEOPLE utilized four kinds of physicochemical properties: secondary
structure, hydrophilicity, surface accessibility, and flexibility (28). BEPITOPE declared
more than 30 propensity scales such as hydrophobicity scales and flexibility (29).
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BepiPred did a similar analysis using a number of propensity scales but using a different
training dataset (30). ABCPred specifically used a neural network to decrease the false
positive rate in predicted linear B-cell epitopes (31). In more recent methods, string
kernals such as spectrum, mismatch, local alignment, and subsequence were applied in
BCPred (33) while amino acid pair propensity was used in AAP (32).
BEOracle/BROracle was based on features from evolutionary, structural and
compositional information of antigen sequences (35). In BEST, optimal models were
trained by combining information from the epitope sequence, sequence conservation,
secondary structure, and relative solvent accessibility (36).
Although different feature combinations based on antigen sequences were
attempted by individual linear B-cell epitope prediction models, it is not yet known which
combination provides optimal prediction performance. Furthermore, it seems that the
“optimal” feature set may be biased by the training dataset chosen by individual research
groups. For example, although BCPred tool received a higher AUC (Area Under receiver
operating characteristic Curve) value than AAP using the Bcipep database, the two tools
demonstrated approximately equal prediction performance when the IEDB database was
used (44).
Another differentiating factor about linear B-cell epitope prediction is the
application of different machine learning platforms. The most common platforms are
Support Vector Machine (SVM) (32, 33), Hidden Markov Model (HMM) (30), and
Artificial Neural Network (ANN) (31). Support Vector Machine is one of the most
popular supervised learning models used for classification, pattern recognition, and
regression. A typical SVM is the binary linear classifier. With the input of two classes of
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classified data, SVM defines the hyper plane as the boundary of two classes by
calculating the maximum margin. The determination of the hyper plane is the main
purpose of SVM algorithms. Derived changes, such as kernel trick in non-linear
classification, may have effect on the hyper plane and be used to modify binary linear
SVM. SVM has been widely applied, especially in the past decade, in the development of
linear B-cell epitope prediction tools such as AAP (32), BCPred (33), BayesB (34),
BEOracle/BROracle (35), and BEST (36). Other tools, such as BepiPred (30), applied
HMM as their platform. HMM algorithms come from the field of statistics. Generally,
HMM is deemed as a Markov model inside which there exists a Markov process
containing unobserved middle states. The optimal model determination is similar to
maximum likelihood estimation of the parameters involved in HMM given the training
sequences. ANN is an information-processing paradigm involved in multiple lines of
interconnected nodes (neurons) computing values from inputs, which has been applied in
the reported linear B-cell epitope tool ABCPred (31). In contrast with SVM and HMM,
ANN algorithms are much more complicated and require more calculation machine time.
4.2.3 Linear B-cell Epitope Prediction Tools
Below we will introduce and compare some popular linear B-cell epitope
prediction tools. PEOPLE (Predictive Estimation Of Protein Linear Epitopes) was
released in 1999 (28). It is a rather sample linear B-cell prediction tool. In PEOPLE, four
kinds of basic properties of epitopes are used: secondary structure (mainly β-turns),
surface accessibility, hydrophilicity, and flexibility. The four kinds of profiles are
combined to calculate an antigenic index (AG). The AG is the final indicator to
determine whether unknown small protein segments are epitopes. Although it is a rather
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simple method, the four properties of epitopes used in PEOPLE are still popular in newly
developed methods for the prediction of linear B-cell epitopes.
BEPITOPE is an updated version of the PREDITOP program developed by
Michael Odorico and Jean-Luc Pellequer in 2003 (29). It is not an online tool and needs
to be installed on local machines. In the BEPITOPE program the authors evaluated more
than 30 propensity scales, such as hydrophobicity (where the negative values indicate
hydrophilic regions, and positive scales stand for flexible regions), to search for potential
epitopes. These propensity scales were calculated by the comparison of real linear B-cell
epitopes and non-epitopes. Hence, for the BEPITOPE program, the collection of epitope
set and non-epitope set and the following calculation of propensity scale is of vital
importance for prediction performance. Although the limited database of linear B-cell
epitopes may limit the success of BEPITOPE, the propensity scales used in BEPITOPE
have proven useful in more recently developed tools.
BepiPred, released in 2006, applied a new strategy to predict linear B-cell
epitopes (30). In BepiPred, the method relied on HMM. Like BEPTIOPE, propensity
scales are the major indicator of epitope properties. The involvement of HMM improved
prediction performance compared with naïve methods like PEOPLE. On its website
(http://www.cbs.dtu.dk/services/BepiPred), the datasets used in BepiPred are also
available. The sharing of datasets can be a good reference for other research groups when
developing and benchmarking their methods, and promotes communication among the
different research groups.
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Like BepiPred, ABCPred also applied an interesting machine learning platform
(31). Recurrent Neural Network is a powerful tool in the field of machine learning and it
was used for the first time in linear B-cell epitope prediction by ABCPred. The dataset
used by ABCPred is from Bcipep (21) after careful filtering of similar epitope sequences.
The process of dataset construction in ABCPred was adopted by many later tools such as
BCPred and AAP. In ABCPred, flexible epitope length was carefully discussed, and the
suggested epitope size was no more than 20 amino acids (AA). To our knowledge,
however, the optimal length of a certain linear B-cell epitope for prediction keeps
unknown.
AAP and BCPred are very popular linear B-cell epitope prediction tools (32, 33).
Both tools are based on the SVM platform and filtered the training dataset from Bcipep
database using a similar filtering process as in ABCPred. BCPred considered string
patterns of epitope sequence while AAP applied amino acid pair antigenicity scale in the
model. In addition, they both investigated and compared different window sizes of
epitopes, such as 10, 12… and 20. AAP was released in 2007 and BCPred in 2008, and
both are available online.
BayesB added new ideas from statistics (34). Bayes feature extraction is a popular
feature in statistical methods, and it was applied in the BayesB tool in 2010 to enhance
the performance beyond SVM-based methods. The two datasets in BayesB were
borrowed from that of AAP and BCPred, again demonstrating the advantage of online
tools and dataset-sharing. The basic scales in BayesB are relevant position-specific amino
acid propensities, similar to those used in BEPITOPE.
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The BEOracle/BROracle (35) tool uses classic strategies for linear B-cell epitopes,
such as composition of protein sequence properties (including secondary structure,
solvent accessibility and evolutionary conservation), the popular platform SVM, and
cross-validation process. Despite this classical approach, it succeeded in generating a
large training dataset due to the availability of the IEDB database (22). The size of a
dataset is of vital importance for the success of the prediction tool. Hence, the IEBD
database gradually replaced Bcipep and became a basic resource for linear B-cell epitope
prediction.
BEST tool was released in 2013 (36). It considers evolutionary profiles generated
by PSI-BLAST. The amino acid pair propensity scale developed for AAP and other
protein sequence properties such as secondary structure and solvent accessibility were put
into consideration by BEST. The increasing number of entries in the IEDB database
offered a bigger training dataset, which benefited prediction performance. The success of
the BEST tool demonstrated the utility of combining different traditional tools with a new
and bigger training dataset.
4.2.4 Principles of Conformational B-cell Epitope Prediction
Conformational B-cell epitope prediction is more challenging than the task of
linear prediction. Similar to linear B-cell epitope prediction tools, physicochemical
properties of amino acid sequence are the major features used in the modeling algorithms.
However, the difference between linear and conformational B-cell epitope predictions is
the collection of training datasets. During the construction of datasets for known
conformational B-cell epitopes, 3D structural information is usually required, which
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presents a huge barrier for conformational B-cell epitope prediction. With more 3D
structures of antigens, the latest conformational B-cell epitope prediction tools generally
outperform their predecessors.
At present, there are a limited number of available conformational B-cell epitope
prediction tools, such as DiscoTope (37), BEpro (PEPITO) (38), ElliPro (39), SEPPA
(41), EPITOPIA (42, 43), and Bpredictor (45). Different tools used different
combinations of features, which may be biased by their own training datasets. For
example, DiscoTope integrated a linear combination of two scores, the hydrophilicity
scale and the epitope log-odds ratio, the latter of which is one kind of epitopic residue
propensity scores (37). BEpro (PEPITO) also applied linear combination to two scores:
the epitopic residue propensity and the half sphere exposure values at multiple distances
(38). ElliPro used only one score, the residue protrusion index (PI) (39). SEPPA
employed the epitopic residue propensity and the compactness of neighboring residues
around one residue (e.g., contact number which is the number of Cα atoms in the antigen
within a distance of 10Å of the Cα atom of target residue), again using linear
combination (41). EPITOPIA applied a naive Bayesian classifier to forty-four
physicochemical and structural–geometrical attributes, including secondary structure,
epitopic residue propensity, evolutionary conservation score, solvent accessibility to the
surface, and hydrophilicity etc (42, 43). Bpredictor employed the Random Forest (RF)
classifier to adjacent residue distance score, accessible surface area, conservation,
secondary structure, and propensity etc (45).
In general, the features used by these predictors include conservation score,
structural features such as secondary composition, geometry characteristics such as
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protrusion index and planarity score, and amino acid features such as hydrophilicity and
propensity (odd-ratio). These attributes can be integrated by linear combination or
machine-learning algorithms, such as naive Bayesian classifiers, Support Vector
Regression (SVR), and RF classifiers. Different numbers of features were used in a given
predictor, from two scores to forty-four attributes. For small numbers of attributes, a
simple linear combination can usually work well, whereas large numbers of features
often require sophisticated machine-learning algorithms to optimally integrate the scores.
Notably, some of these features may be mutually exclusive or overlapping. For example,
the antigenic epitope is frequently located at either a protruding region or a flat surface.
In such cases, linearly combining the two incompatible terms contradicts the physical
situation and will degrade the performance of a predictor. In the next section, we will
introduce these feature applications in several conformational B-cell epitope prediction
tools released in the past decade.
4.2.5 Conformational B-cell Epitope Prediction Tools
Below the popular conformational B-cell epitope prediction tools are introduced
following the order of release dates,
DiscoTope is the first conformational B-cell epitope prediction tool based on
protein 3D structural information (37). DiscoTope uses linear combination to integrate
two scores, the hydrophilicity scale and the epitope log-odds ratio, the latter of which is
one kind of epitopic residue propensity scores (37). Its dataset was a group of 76 X-ray
structures of antibody/antigen protein complexes. Compared with previous sequencelevel tools, the involvement of protein 3D structures offered a more reliable prediction to
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guide experimental epitope mapping. From the training dataset, a log-odds-ratio was
calculated and then applied in the construction of the DiscoTope model. On the other
hand, the tool used simple linear combination rather than popular machine learning
technologies, such as SVM or HMM. Nevertheless, since the release of DiscoTope in
2006, the prediction of conformational B-cell epitopes shifted the focus to utilizing
protein 3D structural data.
PEPITO, released in 2008, tried to improve prediction performance by applying
more features of the 3D structure of antibody/antigen protein complexes, such as multiple
distance thresholds and sphere exposure (38). The dataset of DiscoTope was used by
PEPITO due to the limited availability of antibody/antigen protein complexes in the PDB
database. Amino acid propensity scales, which are usually used in sequence-based linear
B-cell epitope prediction, were also incorporated by PEPITO to enhance predictive
performance.
ElliPro can accept either antigen 3D sequence and structure as input (39). If only
a protein sequence is provided as input, ElliPro will firstly search protein structures in
PDB based on sequence similarity and use the best-matched 3D structure as the input.
ElliPro implemented Thornton‟s method which considers the shape of a protein as an
approximate ellipsoid (40). ElliPro calculates the residue protrusion index (PI) and then
clusters neighboring residues according to their PI values.
SEPPA introduced a concept of „unit patch of residue triangle‟ to describe the
local spatial context on the surface of a protein in 2009 (41). The unit patches were
involved in the calculation of propensity indices and the following antigenicity scores. In
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addition, the method constructed its own training dataset containing 84 structures. The
test set with 119 antigens was from the training set of DiscoTope, IEDB, and Epitome.
Machine learning platforms were not used in SEPPA.
Different from the three tools above, EPITOPIA initiated the application of
machine learning technologies for the prediction of conformational B-cell epitopes (42,
43). It applied a Naive Bayes classifier to the construction of an online tool. A searching
antigen input was firstly divided into overlapping surface patches. For each middle
residue of a patch, its immunogenicity score was calculated by combining
physicochemical and structural properties of the patch. For EPITOPIA, the 3D structure
of the antigen is still a must for online prediction.
We released the two conformational B-cell epitopes EPSVR
(http://sysbio.unl.edu/EPSVR) and a meta server EPmeta (http://sysbio.unl.edu/EPmeta)
in 2010 (44). EPSVR applied the six physicochemical attributes to its surface patch. The
six attributes include epitope propensity, conservation score, side chain energy score,
contact number, surface planarity score, and secondary structure. More details will be
introduced in chapter three.
Bpredictor is a newer conformational B-cell epitope prediction tool released in
2011 (45). For this tool, a new concept of „thick surface patch‟ was introduced to
describe the local spatial context on a protein surface instead of „surface patch‟. It also
compared the influences of different machine learning platforms. For example, SVM and
ANN were found to be slower and more sensitive on parameter settings than RF. As to
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dataset, Bpredictor borrowed the dataset from EPITOBIA and EPSVR (44). The latter is
the conformational B-cell epitope prediction tool we released in 2009.
5. Summary
The importance of B-cell epitope drives us to develop new computational
methods to predict epitopes on protein candidates. Currently the prediction of B-cell
epitopes, including linear and conformational, still has a place to improve. In this
dissertation, from chapter two to chapter four, we will introduce our newly developed
methods to predict linear B-cell epitope (chapter two), conformational B-cell epitope
(chapter three), and epitopic residues on antigen (chapter four) respectively.
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CHAPTER TWO: PREDICTION OF LINEAR B-CELL EPITOPES
1. Introduction
By secreting antibodies against antigens, B-cells play an important role in the
immune system to fight invading pathogenic organisms or substances. An antibody can
specifically recognize and bind to an antigen, analogous to a key into a lock. Antigenic
epitopes are regions of the antigen surface that are preferentially recognized by B-cell
antibodies (1). Prediction of antigenic epitopes is useful for the investigation on the
mechanism of body‟s self-protection systems and can help the design of vaccine
components and immuno-diagnostic reagents (2).
B-cell antigenic epitopes are classified as either continuous or discontinuous (3).
A continuous (also called linear) epitope is a consecutive fragment from the protein
sequence; a discontinuous epitope is composed of several fragments scattered along the
protein sequence, but still form an antigen-binding interface in three dimensions. A
distinction between continuous and discontinuous epitopes is vague; a continuous
fragment in a discontinuous epitope can be considered as a linear epitope. The majority
of currently available epitope prediction methods focus on continuous epitopes due to the
relative simplicity of the problem, in which the amino acid sequence of a protein is taken
as an input. These prediction methods are based upon the amino acid properties including
hydrophilicity (4, 5), solvent accessibility (6), secondary structure (7), flexibility (8), and
antigenicity (9). In addition, based on the epitope databases such as IEDB (10), Bcipep
(11), and FIMM (12), some methods use machine learning approaches, such as hidden
Markov models (HMM) (13), artificial neural networks (ANN) (14), and support vector
machines (SVM) (15, 16), to locate linear epitopes. Such methods include: PREDITOP
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(9), PEOPLE (17), BEPITOPE (18), BepiPred (13), ABCPred (14), AAP (15), BCPred
(16), BayesB (19), BEOracle/ BROracle (20), and BEST (21).
Currently available linear B-cell prediction tools show only a limited success. For
example, one of the best available methods by 2011, BCPred, was reported as the
accuracy and specificity of ~72% and ~79% using the five-fold cross-validation based on
a dataset of 872 B-cell epitopes and 872 non-B-cell epitopes (16).To pursue more reliable
and stable linear B-cell epitope prediction, immunoinformaticists need to develop new
statistical models. The new models shall have lower false positive rates so that the
prediction results can be more reliably used for experimental design.
Since more information including experimentally determined linear B-cell
epitopes and 3D structures of antigens has been released in the past decades, development
of new linear epitope prediction methods became more feasible. For instance, the IEDB
database collects much more known epitopes than before. With the advance in
bioinformatics technology, new algorithms have been developed for the prediction of
active sites of proteins. These innovations stimulate the development of the prediction
tools of linear B-cell epitopes.
In this chapter, we developed a new linear B-cell epitope prediction tool,
SVMTriP, which uses a machine learning technique, SVM, with the tri-peptide similarity
and propensity scores. SVMTriP was tested for varied epitope sequence lengths. With the
five-fold cross-validation, SVMTriP achieves a sensitivity of 80.1% and a precision of
55.2% for sequences with 20 amino acids (AA), which are higher than those of AAP
(sensitivity: 59.8%, precision: 58.5%) and BCPred (sensitivity: 54.0%, precision: 60.5%).
2. Materials and Methods
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2.1 Datasets
The dataset was constructed by extracting non-redundant linear B-cell epitopes
from IEDB (10), which is frequently updated and has the most complete set of linear
epitopes. Total of 65,456 redundant B-cell linear epitopes were obtained from IEDB
(version June 11th, 2012). The identical epitopes and those possibly related to T-cell
were removed. The full-length sequences of corresponding epitopes were also collected.
Then, the various lengths of epitope sequences, including 10AA, 12AA, 14AA, 16AA,
18AA, and 20AA, were extracted by trimming the long experimental measured epitopes
or attaching more amino acid residues to both ends of short epitopes according to the fulllength sequences. For a given length, 65,456 epitope sequences are filtered by a threshold
of less than30% similarity, measured by BLASTP (22), were clustered together and only
one of them was kept as a representative epitope sequence in the dataset. Finally, the
positive dataset for each length had a total of 4925 non-redundant epitope sequences. For
the negative dataset, the same number of non-redundant sub-sequences with each equal
length is extracted from the non-epitopic segments in the corresponding antigen
sequences.
2.2 Attributes
2.2.1 Tri-peptide Scores Matrix
The idea of tri-peptide score matrix was borrowed from the prediction method
used in protein subcellular localization by Lei and Dai (23). A matrix Dk of high scored kpeptide pairs is of dimension 20k × 20k (we did not consider X residue in BLOSUM or
PAM matrix). The tri-peptide score matrix is defined as:
T(i)= ∑(i)  j ,

(1)
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where (i) denotes the tri-peptide that represents the i-th attribute, j denotes the j-th tripeptide in the tri-peptide subsequence space for the input sequence. The symbol “”
denotes getting the similarity score of any two corresponding tri-peptide, i.e., sum of
three similarity scores for three amino acid pairs from a BLOSUM/PAM matrix. For
example, assuming the length of a given epitope candidate is 20 AA, the tri-peptide
subsequence similarity kernel for the i-th attribute is generated by summing over
similarity scores of the 18 pairs of tri-peptide; each pair consists of one tri-peptide from
the input sequence and the tri-peptide represents i-th attribute from the tri-peptide
subsequence space. Using BLOSUM62 as example, the steps are shown below:
a) A sliding window of 3AA along the sequence is used.
b) The score T(i) is defined as the sum of the score for the respective individual
residue pair from BLOSUM62 between two pairs of tri-peptide. The score T(i) is
zero if the sum of BLOSUM62 scores of three individual residue pairs is negative.
c) Each value in 203 features is calculated from the average score T(i)s between the
ith tri-peptide and all of tri-peptides from step a.
A graphic interpretation is shown in Figure 2.1
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Figure 2.1 Illustration of tri-peptide score matrix construction. Each feature score is
the average score of between the ith tri-peptide and all the peptides from slide window of
protein sequence.

To build the tri-peptide score matrix, BLOSUM and PAM matrices, the most
popular score matrices used for protein sequence alignment, were tested. BLOSUM
matrices are derived from residue-residue substitution probability (24) while PAM is
based on observed mutations of closely related proteins (25). In our study, different
BLOSUM matrices were tested, such as BLOSUM30, BLOSUM50, BLOSUM62, and
BLOSUM75, where the number represents the percentage identity threshold that are used
for determining closely related protein groups during the construction of BLOSUM
matrices. Different PAM matrices were used as well, such as PAM120, PAM160,
PAM200, and PAM250, where the number stands for the times of multiplication of the
primary PAM matrix (PAM1) by itself when building a PAM matrix. The application of
different BLOSUM or PAM matrices would influence the prediction result of final
models.
2.2.2 Tri-peptide Subsequence Propensity
The propensity of tri-peptide subsequence representing the i-th attribute is
calculated as in Equation (2):
P (i) =

f (i ) ,
F (i )

(2)

where f(i) is the frequency of i-th type of tri-peptide in the positive epitopes, and F(i) is the
background frequency of i-th type of tri-peptide in 5×104 protein sequences randomly
selected from the Refseq database (26).
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2.2.3 Integrations of Tri-peptide Scores Matrix and Tri-peptide Subsequence
Propensity
The tri-peptide subsequence space is used to encode the SVM attributes. This
kernel has a space of 203 attributes for both tri-peptide substring and propensity. The
score of i-th attribute, K(i), is defined as the tri-peptide subsequence similarity kernel
modulated by its corresponding tri-peptide propensity. Please see Equation (3):
K(i) =T(i) •P(i),

(3)

where K(i) denotes the score of the i-th attribute, T(i) denotes the i-th tri-peptide score
matrix calculated by Equation (1), and P(i) denotes corresponding tri-peptide subsequence
propensity of i-th tri-peptide subsequence calculated by Equation (2). Other features of
physicochemical properties of amino acids, such as hydrophilicity and predicted
secondary structure, had been also used to modify K(i). For hydrophilic and hydrophobic
residue group, two fixed weights, e.g., 0.5 and 2, will be used to change K(i).
2.2.3 Hydrophobicity
Hydrophobicity scale of residue usually is applied to linear B-cell epitope
prediction (17, 18). The hydrophobicity profile implies a hydrophobic region that tends to
be located away from the surface of antigen protein. A potential hydrophobic region
represents a low probability to be an antibody-bind site. Hence, hydrophobicity scale
was used here in order to evaluate the probability of a residue locating on protein surface.
Table 2.1 Hydrophobicity Scale Table
Ala 1.8 Glu -3.5
Arg -4.5 Gln -3.5
Asn -3.5 Gly -0.4
Asp -3.5 His -3.2
Cys 2.5 Ile 4.5

Leu 3.8 Ser -0.8
Lys -3.9 Thr -0.7
Met 1.9 Trp -0.9
Phe 2.8 Tyr -1.3
Pro -1.6 Val 4.2
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Amino acid hydrophobicity scales may be calculated by experimental biophysical
methods. In our study, we used the hydrophobicity scale calculated by Jack Kyte shown
in Table 2.1 (27).
2.2.4 Secondary structure
The structural information directly declares the spatial location where the residues
stay. 3D structure is of the most interest but it is also challenging to predict. There are,
however, many mature secondary structure prediction methods available and the results
from those tools usually are more reliable. Hence, many linear B-cell epitope prediction
tools incorporate secondary structural data to their models (17, 20). We also considered
secondary structure information.
To obtain the secondary structural information of antigen, we applied one of the
popular protein secondary structure prediction tools, PSIPRED, which is based on
position-specific scoring matrices (PSSM) from PSI-BLAST. In order to run a PSIPRED
tool on a local machine, the BLAST tool and the associated NR database must also be
downloaded and installed correctly. PSIPRED tool package is available on
http://bioinfadmin.cs.ucl.uk/downloads/psipred/ (28) and BLAST can be downloadable
from National Center for Biotechnology Information (NCBI) website
(ftp://ftp.ncbi.nlm.nih.gov/blast/ executables/blast+/LATEST/) (22).
2.3 Support Vector Machine Platform
Support Vector Machine (SVM) was selected as the machine learning technique
for our new models. SVM has been proven powerful in various biological and
immunological applications, such as epitope prediction (15, 16), disease diagnostic (29,
30), clinical outcome (31), and hub protein determination (32). SVM usually is associated
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with learning algorithms for the application of classification and regression analysis. For
example, a typical application is to generate binary linear classifier. SVM takes a set of
two classes of objects as an input. By fitting the maximum-margin hyperplane, SVM
determines the boundary between the two classes in a hyper-dimensional space. SVM
then classifies an unknown object by checking where the unknown object is located
besides the hyperplane in the hyper-dimensional space. Since developed by Vladimir N.
Vapnik in 1963 (33), the theory of SVM has been differentiated into multiple branches,
including linear model and nonlinear model, binary class SVM and multiclass SVM, and
classic supervised learning SVM and semi-supervised transductive SVM. Many different
SVM tools have been developed as listed in Table 2.2. Here we used SVMlight as a
platform to train the optimal model. SVMlight is an easy standalone tool with customizable
parameter options. It has been successfully applied in many SVM-based biological
predictions, such as protein fold recognition.

Table 2.2 Some Available Support Vector Machine Tools
SVM Tool
SVMlight (34)
SVMstruct (35)
mySVM (36)
TinySVM
LIBSVM (37)
SVMTorch (38)
LS-SVMlab (39)

Downloadable Access
http://svmlight.joachims.org/
http://svmlight.joachims.org/svm_struct.html
http://www-ai.cs.uni-dortmund.de/SOFTWARE/MYSVM/index.html
http://chasen.org/~taku/software/TinySVM/
http://www.csie.ntu.edu.tw/~cjlin/libsvm/
http://bengio.abracadoudou.com/SVMTorch.html
http://www.esat.kuleuven.be/sista/lssvmlab/

2.4 Model Training and Evaluation
2.4.1 Training Procedure
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The SVMlight platform applies a series of parameters to obtain the optimal training
models. Some important parameters include kernel type, c (trade-off between training
error and margin), g (parameter γ of the radial basis function kernel), and p (fraction of
unlabeled examples to be classified into the positive class). In our training procedure, we
applied the popular kernel of the radial basis function. All SVM parameters were
optimized by a grid search (c=2-10~-1, g=2-12~-3, and p=2-5~-2). For each grid point of the
triplets (c, g, and p), a five-fold cross-validation procedure was employed to evaluate the
performance of the trained SVM model. To carry out the five-fold validation procedure,
we ran pair-wise similarity comparison to the training dataset. The total of 4925 positive
epitopes were split into five groups, and any two-epitope sequences from two different
groups did not have sequence similarity more than 20%. At each triplet point, the Fmeasure was calculated as shown in equation (4). F-measure quantifies a tradeoff of
sensitivity and precision in prediction performance. The optimal parameter set has the
largest value in all points with the maximum F-measures. During the procedure of fivefold cross-validation, five test results were used to calculate the mean values and 95%
confidence intervals of sensitivity, precision, and the maximal F-measure.
To optimize the parameter set during the process of SVM training, the three
performance statistics, sensitivity, precision, and F-measure as defined in Equation (4)
were used as the major criteria. Sensitivity, also called recall, is used to check the
proportion of true B-cell linear epitopes identified as positives from all actual positives.
Precision represents the proportion of true positives from the predicted linear B-cell
epitopes. These two statistics are of the most interest of immunologists when predicting
linear B-cell epitopes. However, they showed different trends with the change of SVM
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parameter sets. One example is shown in Figure 2.2. During our training, when
decreasing the value of g (parameter γ of the radial basis function kernel) precision would
go down while sensitivity would go up. Therefore, to determine the optimal g value, we
can select g value from the cross point in the graph. the optimal parameter set is decided
by the maximization of F-measure.
We also attempted different types of kernel functions in SVMlight, such as linear,
polynomial, and radial basis. The final kernel in our models focused on the radial basis
function after comparing their performance.

Figure 2.2 Curve of precision and sensitivity with different g values in SVM
classifier training. g is parameter γ of the radial basis function kernel. The blue curve
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stands for precision and the gray curve for sensitivity. Usually, the maximum F-measure
can be found at the cross point of two curves where a optimal g parameter is determined.
2.4.2 Statistical Evaluation
To evaluate the prediction performance of linear B-cell prediction tool,
performance statistics including sensitivity (Sen), specificity (Spe), precision (Pre),
accuracy (Acc), Mattews correlation coefficient (MCC), and F-measure (F) are calculated
by Equation (4) below,

TP
 100%
TP + FN
TN
Spe =
 100%
TN + FP
TP
Pre 
 100%
TP + FP
TP  TN
Acc =
TP + FP  TN  FN
(TP)(TN)- (FP)(FN)
M CC =
(TP  FP)(TP  FN)(TN  FP)(TN  FN)
Sen =

F

(4)

2  Pre  Sen
,
Pre + Sen

where TP, TN, FP, and FN stand for true positive, true negative, false positive, and false
negative, respectively. All of calculations above are based on five-fold cross-validation
procedure.
Another statistical measure, AUC, is also calculated. AUC is the "area under the
curve" where the curve is a receiver operating characteristic (ROC) curve. In the ROC
curve, sensitivity, sometimes called TPR (True Positive Rate), is plotted against FPR
(False Positive Rate), i.e. FPR = FP / (FP + TN). A higher AUC score represents higher
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prediction performance. A java program available at
http://pages.cs.wisc.edu/~richm/programs/AUC/ was used to calculate the AUC.
Although higher AUC values mean better prediction performance, the
significance of two AUC score difference must be considered, too. Not significantly
different AUCs mean that the two classifiers show equal performance when classifying
unknowns. The online tool StAR was used to test whether the difference between ROC
curves resulting from two models was statistically significant (40, 41).
2.5. Online Prediction Tool
We have also released an online tool for public use. The online tool SVMTriP is
available on online (http://sysbio.unl.edu/SVMTriP). The major architect of this tool is
shown in Figure 2.3. In the SVMTriP website, the online prediction tool contains three
parts, 1) the identified optimal models based on SVM training with carefully-selected
parameter sets; 2) a database used to store the requests from customers and the final
prediction results after SVM classification by optimal models; and 3) a background
server that implements the key process of SVM classification. The technologies involved
in the SVMTriP online tool include Perl scripts, PHP, and My-SQL database. Blast
Converting is applied to initial search of protein candidate in known epitope training
dataset.
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Figure 2.3: The illustration of the SVMTriP online tool
For the application on the online server, the prediction model is obtained by
training SVMs using the datasets as described in the previous sections. To predict
epitomes from a given full-length protein sequence, the sliding window method is
employed to obtain subsequences with variable window sizes including 10AA, 12AA,
14AA, 16AA, 18AA, and 20AA with a step size of 2AA. For each subsequence,
SVMTriP calculates its score, and a positive score indicates that the subsequence is a
putative antigenic epitope. Based on the testing results, 20AA was set as the default
epitope length for SVMTriP to search for putative epitopes on the web server.
3. Results
3.1 Prediction performance
SVMTriP is trained and tested with different epitope lengths, and for each length,
the SVM parameters have their independent optimal values. For example, for 20AA-
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length cases, SVMTriP reaches its optimal performance at c=32, g=0.05, and p=0.5 for
the SVM model with Sn=80.1%±2.1% and P=55.2%±1.0% at the point with the maximal
F-measure, 0.693. All results are shown in Table 2.3. Though, for different lengths of
epitope sequences, SVMTriP has various points with the maximal F-measure, the
precision values for different lengths are similar. The sensitivity increases significantly as
the length of the epitope sequences increases. The range of the values of areas under the
receiver operating characteristic curves (AUC) is from 0.674 to 0.702. Based on results of
the performance assessment, SVMTriP for 18AA- and 20AA-length cases have the best
performance. However, one may note a fact that most of experimentally determined
epitopes from IEDB have less than 20 AA residues. A possible reason why SVMTriP
favors long length of sequences is that a long sequence may have more tri-peptides to
show a detectable frequency tendency. Another possibility is that the epitopic amino acid
residues in experimentally determined epitopes are subsets of all real epitopic residues.
Based on the testing results, 20AA is set as the default epitope length for SVMTriP to
search for putative epitopes on the web server.
3.2 Comparison with AAP and BCPred
For comparison, AAP and BCPred are implemented locally based on their method
descriptions, trained/tested with the same dataset and the five-fold cross-validation
procedure for 20AA case. The results are listed in Table 2.4. Compared with BCPred and
AAP, SVMTriP has a similar precision value, but significantly improved sensitivity at the
point with the maximal F-measure. Figure 2.4 shows the ROC curves for the three
methods. One may notice that SVMTriP has significantly larger sensitivity than BCPred
and AAP in the region of low false positive rate. The AUC values are 0.667, 0.667, and
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0.702 for AAP, BCPred, and SVMTriP, respectively. The AUC value of SVMTriP is
significantly higher than those from the other two methods; the p-values of comparison
against AAP and BCPred are 2.17×10-5 and 1.58×10-5, respectively.
Table 2.3 Performance of SVMTriP models with different epitope lengths
Length (AA)
10
12
14
16
18
20

Sn (%)
68.5 ±2.5
67.5 ±3.5
64.8 ±4.9
63.5 ±5.5
79.0 ±1.9
80.1 ±2.1

P (%)
55.5 ±1.5
57.0 ±2.0
56.5 ±2.5
57.1 ±3.0
54.1 ±1.1
55.2 ±1.0

F-measure
0.615 ±0.020
0.620 ±0.030
0.605 ±0.030
0.601 ±0.045
0.641 ±0.015
0.693 ±0.060

AUC
0.674
0.681
0.689
0.685
0.666
0.702

Table 2.4 Performance of different linear B-cell epitope prediction methods

*

Methods

Sn (%)

P (%)

F-measure

AUC

AAP*

59.8 ±0.9

58.5 ±6.5

0.590 ±0.040

0.667

BCPred*

54.0 ±7.1

60.5 ±2.5

0.572 ±0.055

0.667

SVMTriP

80.1 ±2.1

55.2 ±1.0

0.693 ±0.060

0.702

The results for AAP and BCPred, are obtained by the software implemented locally.
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Figure 2.4 ROC curves for AAP, BCPred, and SVMTriP
4. Discussion
4.1 Determination of Different Models
The determination of linear B-cell epitope prediction models relies on different
factors. The first consideration is the length of epitopes. The range of epitopes
determined experimentally usually varies from 5 to 30AA. The optimal length of B-cell
epitopes for computational prediction is unknown. Results obtained by ABCpred
suggested the epitope length in statistical models should be no more than 20AA (14). In
this study, we set up individual models with different epitope lengths. Another factor is
the combination of features used in models. The optimal combination of features is also
not clear. Based on different training datasets, the optimal feature set in different linear
B-cell epitope prediction models may be quite different. Hence, in this study, we also
determined the optimal combination of specific features with statistical evaluation.
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The optimal window size for linear B-cell epitope is yet another unknown. We
noticed that among the reported linear B-cell epitopes, over 60% were with the length of
12-18AA. During the process of learning, there can be a minor deviation between the
optimal window size for prediction and the average length of real linear B-cell epitopes.
For example, the function of B-cell linear epitopes is potentially influenced by the
neighboring residues. Hence, a longer sequence segment embedding linear epitopes may
contain more useful information. Therefore, in our learning procedures, we attempted
various lengths of slide window, including 10AA, 12AA, 14AA, 16AA, 18AA, and
20AA.
Our training showed the optimal model came from the combination of tri-peptide
score matrix and tri-peptide subsequence propensity. The hydrophobicity and predicted
secondary structure scales did not contribute to final model SVMTriP. The optimal
SVMTriP model was based on tri-peptide score matrix and tri-peptide subsequence
propensity.
4.2 The Influence of Different Kernels on SVMTriP Models
4.2.1 Prediction with tri-peptide propensity alone
The propensity of tri-peptide alone is tested and the result is shown in Table 2.5.
The prediction sensitivity is 56.5%, which is little smaller than 59.8% of AAP, a method
based on bi-peptide propensity. On the other hand, the precision of tri-peptide propensity
is 61.0%, which is similar with AAP‟s precision of 58.5%. This result indicates that
combining similarity scores is essential for the tri-peptide model to achieve a better
performance.
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4.2.2 Prediction with tri-peptide similarity alone
The tri-peptide similarity scores can be calculated with either Blosum62 or
PAM160 matrixes (the results of Blosum and PAM metrics are not shown here). The
performance of two different matrices for the tri-peptide model is evaluated with the
same procedure of the five-fold cross-validation for 20AA-length epitopes. The results
are shown in Table 2.5. Without the propensity score, using Blosum62 matrix shows
similar performance as using the PAM160. However, when combined with the propensity
score, Blosum62 matrix leads to a higher prediction performance.
4.2.3 Discrete tri-peptide subsequence models
We also implement a method that uses the space of tetra-peptide subsequence
with one mismatch, i.e., discrete tri-peptide subsequences. For this case, the
subsequences are considered in patterns either A_AA or AA_A, where „A‟ represents the
amino acid residue to be considered and „_‟ represents the residue position that will be
ignored in the comparison. The number of SVM attributes is still 203, which is identical
to that of the tri-peptide model. Interestingly, as shown in Table 2.5, without considering
propensity scores, the subsequence models of A_AA and AA_A patterns have similar
sensitivity and precision with the tri-peptide model. However, the combination of
similarity and propensity of the tri-peptide model significantly enhances the performance,
while addition of the propensity does not increase sensitivity and precision for A_AA and
AA_A patterns. This finding indicates that the propensity is more important for the tripeptide model than the discrete tri-peptide subsequence model.
Table 2.5 Comparison among the tri-peptide subsequence models with or without
propensity
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Sn (%)
P (%)
F-measure
N.A.
56.5 ±12.5 61.0 ±6.3 0.584 ±0.085
Blosum62 54.5 ±6.5 60.5 ±1.5 0.573 ±0.035
w./o. Propensity
PAM160
55.0 ±7.2 61.1 ±1.8 0.578 ±0.040
Tri-peptide
Blosum62* 80.1 ±2.1 55.2 ±1.0 0.693 ±0.060
w./ Propensity
PAM160 69.3 ±10.0 58.5 ±3.5 0.633 ±0.050
Blosum62 54.8 ±6.8 60.5 ±1.5 0.579 ±0.040
w./o. Propensity
PAM160
55.2 ±7.1 61.3 ±2.0 0.577 ±0.045
AA_A
pattern
Blosum62 60.5 ±5.5 57.5 ±2.5 0.589 ±0.040
w./ Propensity
PAM160
59.5 ±5.5 57.5 ±1.5 0.585 ±0.035
Blosum62 55.5 ±8.5 60.6 ±2.2 0.581 ±0.050
w./o. Propensity
PAM160
55.2 ±8.1 60.5 ±1.5 0.577 ±0.055
A_AA pattern
Blosum62 60.5 ±6.5 57.5 ±1.5 0.590 ±0.040
w./ Propensity
PAM160
59.5 ±5.5 57.5 ±1.5 0.585 ±0.025
*
The parameter set with Blosum62, Tri-peptide, and propensity were chosen to
determine the optimal model of SVMTriP
Tri-peptide

Kernels
Propensity only

4.2.4 Top weighted tri-peptide
The prediction model relies on the occurring-frequency distribution of tri-peptides
in the tri-peptide space, i.e., all combinations of any three amino acids. In Table 2.6, tripeptide with top 20 weights in the optimal SVM model of 20AA-length epitopes are
listed. All of the top ranked tri-peptides contain Glutamine or Proline, whereas the
occurring frequencies of Glutamine and Proline in known linear epitopes (20AA) are
only 8.1% and 6.84%, respectively. In the background of overall proteins, the occurring
frequencies of Glutamine and Proline are 3.84% and 3.44%, which is not significantly
different to the values in linear epitopes. The tri-peptide containing Glutamine or Proline
may play an important role in epitope recognition by B-cell antibodies. The algorithm of
SVMTriP successfully utilized this difference to distinguish linear epitopes from other
parts of protein peptides.
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Table 2.6 Weights of tri-peptides in the optimal SVM model
Tri-peptide Rank Weight Score*

Tri-peptide Rank Weight Score*

QQP
1
503251.79
GQQ
11
121677.62
PQQ
2
488627.71
QPY
12
116598.60
QPQ
3
367386.40
YPQ
13
113237.37
QPF
4
246462.39
QQF
14
81709.59
FPQ
5
234868.65
PYP
15
79191.37
PQP
6
231353.73
FQQ
16
77357.97
QGQ
7
153161.76
PPP
17
76320.05
PFP
8
151840.02
QPP
18
64756.05
QQQ
9
128930.20
QFP
19
63814.16
QQG
10
122291.90
PPQ
20
63173.33
*
Weight scores are calculated by the formula w =∑αixi. Here αi is dual representation
of the decision boundary; and xi (i=0, 1, 2…n) is vector described in SVM model. Both
αi and xi are available in the model file.
4.3 Independent Test to Compare SVMTriP and Other Linear B-cell Epitope
Prediction Tools
Another independent test was developed as a tendency test between virus and
human proteins by BCPred, AAP, and SVMTriP. Independent testing of different epitope
prediction methods is challenging because of the limited number of known epitopes. In
this study, we devise an alternative independent test method. In the training set, most
epitopes are from virus or bacteria, and their corresponding antibodies are mainly human
antibodies. A basic property of the human immune system is the capability to distinguish
any pathogenic agents, viral or bacterial, from the innate structures of the human being.
All known B-cell epitopes in the training set came from the response of whole immune
system, including the response of CD4 T helper cells. Trying to simulate the human
immune system, a successfully trained epitope prediction method should act the same, i.e.,
be able to distinguish pathogenic proteins from human proteins. In other words, the virus
proteins should be preferentially more highly scored than human proteins by a successful
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prediction algorithm. To implement this test, 105 20AA-length peptides are collected
from virus and human proteins: 5×104 peptides are randomly selected from 391,466 virus
proteins and others from 81,967 human proteins in the NCBI Refseq protein database.
AAP, BCPred, and SVMTriP are applied to these virus and human peptides, and topranked peptides are returned. The fractions of virus peptides in different numbers of topranked peptides are shown in Figure 2.4. All three methods returned more virus peptides
than human peptides within the top-ranked peptides. SVMTriP, however, selected higher
percentage of virus peptides than both AAP and BCPred. For example, in total 400 topranked peptides returned by SVMTriP, 90.5% of them, i.e. 362, are virus peptides. There
are 47.8% (191) and 56.5% (226) virus peptides returned by AAP and BCPred,
respectively. This indicates the exceptional ability of SVMTriP to distinguish epitopic
and non-epitopic peptides.

Figure 2.4 Tendency test for BCPred, AAP, and SVMTriP. Three bars at the same
point on the x-axis are the results for APP (blue), BCPred (green), and SVMTriP (red),
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respectively. In the same bar, the light part is for the number of returned human peptides,
and the dark part is for virus. For example, at the point of 400 returned peptides, the dark
part in the red bar is 362, which means that 362 viral peptides are return in all 400
peptides by SVMTriP, and the light red part represents 38 human peptides.
4.4 The Challenge of Linear B-cell Epitope Prediction
Although the prediction of linear B-cell epitope has achieved some success, we
are still not fully satisfied with currently available tools. One of major issues is still rather
high false positive rates. The main reason is that antibody-binding sites on antigens are
much less conserved than other types of binding sites. The predator-prey game between
antibody and antigen has changed the triumphal side many times during the evolutionary
history. Antigen tried to avoid the recognition and clearance by antibody by changing its
active sites, while antibody does all the best to figure it out and bind to the antigen. As a
consequence, the binding sites on antigen, i.e., epitopes, show less conservation and
lower sequence similarity. At present, almost all of linear B-cell epitope prediction tools,
including SVMTriP, are based on the assumption of conservation and sequence similarity
among known linear B-cell epitopes. This is a dilemma between evolutionary immunepressure and computational algorithms. One possibility is that B-cell antibodies show
certain favorite binding pattern on antigen considering their special Y-shapes.
Another uncertainty in these available prediction tools is from the training
datasets used. Obviously the datasets are of vital importance for prediction performance.
The known linear B-cell epitopes mostly were determined by well-designed experiments.
However, such experimental determination is slow and fund-consuming. Moreover, these
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experiments usually focus on specific disease-related antigens which people are more
interested in. The bias in datasets used for training linear B-cell epitope prediction
methods influences the identification accuracy. With a limited number of available linear
B-cell epitopes, Blythe and Flower (42) showed that propensity based methods cannot be
used reliably for predicting B-cell epitopes, which could only yield success rate
marginally better than random prediction. A bigger non-redundant dataset should be one
of key factors in future development of improved linear B-cell epitope prediction
methods.
We also compare the specificity of linear B-cell epitope prediction compared to
other protein-protein interaction prediction. For example, given the interaction between
antibody and antigen is usually transient non-obligate, the binding tends to be one kind of
rather weak interaction (43). It means that residues of antibody and antigen proteins are
involved in temporary and unstable adjacency. Special properties of these residue-residue
bonds potentially affect the performance of algorithms which based on conserved and
stable residue-residue interaction, such as some protein-protein binding site prediction
tool (44). Hence, it is difficult to simply use prediction methods for regular proteinprotein interaction in epitope prediction.
We developed a new method, SVMTriP, to predict linear antigenic epitopes.
Applied to non-redundant B-cell linear epitope data extracted from IEDB, SVMTriP
achieves a sensitivity of 80.1%, a precision of 55.2%, and AUC of 0.702 with five-fold
cross-validation. The combination of similarity and propensity of tri-peptide
subsequences can improve the prediction performance for linear B-cell epitopes.
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Moreover, SVMTriP is capable of recognizing viral peptides from human protein
sequences effectively.
The SVMTriP website collects the queries from users and stores them as the job
queue in the database. The local service checks these queries and completes the searching
along the input antigen sequence one by one. The predicted linear B-cell epitopes will be
stored in the database and sent to the Result webpage. Generally, under a normal job load,
a complete search on 200AA-length antigen needs about 20 minutes.
On the SVMTriP website, we also released the training dataset extracted from
IEDB database as of June 11th, 2012 (http://sysbio.unl.edu/SVMTriP/download.php).
This dataset is a non-redundant linear B-cell epitope set containing 4925 entries. For each
entry, we obtained the real epitope segments and the full-sequence of the corresponding
antigen. We extended or subtracted real epitope segments to construct 10AA, 12AA,
14AA, 16AA, 18AA, and 20AA subset. These datasets may be used to similar model
training for new B-cell linear epitope prediction tools using other training features or
algorithms.
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CHAPTER THREE: PREDICTION OF CONFORMATIONAL BCELL EPITOPES
1. Introduction
Conformational B-cell epitopes are discontinuous segments along antigen
sequence and they are responsible to the interaction between antigen and antibody. A
conformational epitope is usually composed of several shorter antibody-binding regions
physically separated on antigen sequence. Therefore, a conformational B-cell epitope can
be considered as the union of multiple distinct shorter linear B-cell epitopes. These short
linear B-cell epitopes are located independently on the surface of antigen. Therefore, it is
also possible each of these linear epitopes belongs to different chains of the antigen if a
quaternary structure of multiple polypeptide chains exists in the antigen protein (1, 2).
The distribution of subunits of conformational B-cell epitopes gives a hint for the 3D
structural shape of the entire antigen protein. Determining conformational B-cell epitopes
approximately equals to identifying the binding surface structure of antigen proteins.
Usually in the process of identification conformational B-cell epitopes experimentally,
resolving 3D structures of antigen proteins is the primary strategy. Protein 3D structures
can be determined by the nuclear magnetic resonance (NMR) or the X-ray
crystallography, both highly time-consuming. In the Protein Bank Database, therefore,
there is only a very limited number of structures of antigen-antibody complexes (3).
Although accurate prediction of antigenic epitopes is needed for immunological
research and medical applications, it is still a challenging task. Prediction of
conformational B-cell epitopes seems more difficult so currently there are only a few
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such methods available. The lack of 3D structures of antigens is the main barrier. Without
3D structural information of antigen binding to antibody, it is difficult to identify
discontinuous subunits of conformational B-cell epitopes and to construct a positive
training dataset for prediction methods. As we discussed, the reliable and unbiased
positive training dataset is the key for the success of conformational B-cell epitope
prediction. All discontinuous epitope prediction methods require the three-dimensional structure
of the antigenic protein. The small number of available antigen-antibody complex structures
limits the development of reliable discontinuous epitope prediction methods and an unbiased
benchmark set is very much in demand (4, 5).

Although discontinuous epitopes dominate most antigenic epitope families (6),
due to their computational complexity, only a very limited number of prediction methods
exist for discontinuous epitope prediction". It also reads much better. Currently only
several conformational B-cell epitope prediction tools are available: CEP (7), DiscoTope
(8), BEpro (PEPITO) (9), ElliPro (10), SEPPA (11), EPITOPIA (12, 13) and EPCES (4),
and Bpredictor (14). Due to unsatisfactory performance of currently available methods,
we developed new tools aiming to improve prediction reliability of conformational B-cell
epitopes. In this section, we introduce an antigenic Epitope Prediction method by using
Support Vector Regression (EPSVR) with six attributes: residue epitope propensity,
conservation score, side chain energy score, contact number, surface planarity score, and
secondary structure composition. With an independent test dataset, we compare EPSVR
against other conformational B-cell prediction tools. EPSVR and its related resources are
available on http://sysbio.unl.edu/EPSVR.
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The idea of consensus results to improve confidence of prediction is popular in
bioinformatic research. For example, ensemble method for gene prediction may integrate
multiple single predictions. Among known conformational B-cell epitope prediction tools
released, most of them have their own biased results due to its specific training datasets.
To decrease the biased influences, a meta server can be used to obtain a consensus output
from multiple prediction tools.
The success of the meta server also depends on the prediction performance of
each member. We first consider the prediction performance of each method reported in
literatures. The attributes used in prediction must be taken into consideration. Prediction
would be biased if some attributes are used repeatedly in multiple methods. We also have
to pay attention to the training sets used in those tools. Use of similar training datasets in
multiple tools may cause bias in prediction. A good meta server should include methods
based on a wide range of training sets. Finally, the availability of tools is also a
requirement if we want to install it locally or obtain the results online for further
consensus analysis. For example, because CEP tool is no longer available online, we
removed it from our candidates. Similarly, we did not include ElliPro because it was not
available for download.
Our EPmeta server incorporates EPSVR, EPCES, EPITOPIA, SEPPA, PEPITO,
and Discotope1.2. Prediction is done by each tool individually first. The outputs from the
six tools are combined together to generate a single consensus output. With an
independent test dataset, EPmeta showed a more confident prediction than its each
member. The EPmeta server is available at http://sysbio.unl.edu/EPmeta.
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2. The Development of Novel Conformational B-cell Epitope Tool, EPSVR
2.1 Dataset collection
a) Training Dataset
The training set was gathered and screened from three protein datasets: 1) 22
antigen-antibody complexes and their unbound structures from protein docking
Benchmark 2.0 (15); 2) 59 representative antigen-antibody complexes compiled by
Ponomarenko and Bourne (5); 3) 17 antigen-antibody complex structures released
between February 2006 and October 2008 with available unbound antigen structures,
which was the test set use in EPCES server (4). Any antigen-antibody complex was
discarded if its antigen had no available unbound structure because the unbound
structures were required for prediction. A complex structure was not used if its antigenic
epitope consisted of amino acid residues located on multiple chains. A complex was
included if the sequence identity between its antigen and all other antigens from the other
complex structures was less than 35% following local sequence alignment. For an antigen
with a sequence identity in the range of 35~50%, we accepted the antigen-antibody
complex if the binding topology was not the same as its homologous complex. For an
antigen with more than one antigenic epitope, only one was used in order to avoid
confusion in subsequent application of support vector regression methods. As a result, a
total of 48 complexes and their unbound structures meeting the above criteria were used
as a training set.
b) Testing Dataset
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The test set was curated from 293 entries of the Conformational Epitope Database
(CED, Release 0.03) with the following criteria (16). We only considered entries that had
unbound antigen structures, but no complex structures. Multiple entries with the same
antigen structure were combined and considered as one target, and antigenic residues
from multiple entries were mapped onto one protein structure. The sequence identity
between any two selected proteins was also required to be less than 35%. All selected
antigens were also screened against the rest of CED database and our training set; the
sequence identity between a selected antigen and other antigens with complex structures
in the CED or in the training set was less than 35%. A total of 22 antigenic proteins in the
CED met all the above criteria; these were: 1www, 1hgu, 1eku, 1mbn, 1av1, 1pv6, 1al2,
2gmf, 1a7c, 1y8o, 1og5, 1jeq, 1dab, 1w7b, 1ly2, 1rec, 1nu6, 2b5i, 2gib, 1p4t, 1xwv, and
1qgt. Three antigenic proteins, 1www, 1hgu, and 1xwv, were excluded since they had
multiple antibody-binding sites and the mapped antigenic residues were evenly
distributed on the protein surfaces. Therefore, the final test set contained 19 antigen
structures.
2.2 Attributes
Six attributes were used to antibody binding site prediction.
a) Epitope propensity
Epitope propensity at the amino acid position i, Epropensity (i), is defined as

Epropensity (i) = (ln

Printerface
Sr
) ´ ave
surface
Pr
Sr

(1)
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where Printerface and Prsurface represent the probabilities of residue type r located on
antibody-binding interface or just on the surface of antigen protein, respectively. They
were calculated based on the residue types from the antigen proteins in the training set.
All of epitopic residues were considered to be at the antibody-binding interface.
Parameters Sr and Srave are the relative accessible surface area of residue r at the sequence
position i and the average relative accessible surface area of surface residues of type r,
respectively. The Cα atom of Gly is considered as a side chain atom for convenience (17).
Since antigen-antibody interfaces have different residue composition compared with
other protein-protein interfaces, we used the training dataset to derive residue-specific
antibody binding site propensities in epitopes and background proteins.
b) Conservation score
A residue conservation score relies on position-specific substitution matrix
(PSSM), which is obtained by three rounds of searches using PSI-BLAST (18) starting
with the BLOSUM62 substitution matrix. The conservation score at the position i is
defined as
|M - Brr|, if M ir - Brr  0,
Econserv (i)= ir
0, if M ir - Brr  0


(2)

where Mir is the position-specific score in PSSM for the residue type r at sequence
position i, and Brr is the diagonal element of BLOSUM62 for residue type r.
Conservation score is set to 0 if the position-specific score after three rounds of PSIBLAST search is larger than the original position-specific score in BLOSUM62 (17). As
we discussed in chapter two, epitopic residues show lower conservation than other
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functional residues of most of non-antigenic proteins. In contrast to regular proteinprotein interaction where conserved surface residues in the unbound structure are
considered as interface residues, the poorly conserved residues of antigen are considered
as the putative antibody-binding site residues due to adaptive evolutionary pressures for
antigen proteins.
c) Side-chain energy score
Side-chain energy can influence protein structural conformation and further
function on the spatial context of protein surfaces. Side-chain energy score is calculated
from the side-chain energies of all possible rotamers for a given residue type at a
sequence position whereas other sequence positions have native residue types and
observed atomic coordinates. The weights of the energy function are optimized so that
the native residue was predicted energetically favorable at each position of the training
proteins. The assumption is that the residues at the antibody binding site have a higher
energy score than other surface residues so that the free energy of the antigen-antibody
system could go down significantly upon association.
The definition of side-chain energy score was given in Liang and Grishin (19).
The energy unit is kcal·mol−1. The side-chain energy score of amino acid i is defined as,

Eside chain (i) = - f ln

{å exp [-E
R

side chain

}

(Ri )]

(3)

where the summation is over all the rotamers available for a given residue type and the
constant prefactor f = 1/2.41, which is from the slope of the regression line between the
calculated and experimentally measured unfolding ΔΔG of a set of point mutation data.
Ri is a given rotamer of residue i and Eside chain (Ri) is defined as,
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Eside chain (Ri ) = - 0.143 Scontact + 0.724 Voverlap + 1.72 Ehbond + 28.6 Eelec
- 0.0467Spho + 0.0042Sphi + 1.14 (Fphi )30 + 7.95 Vexclusion - 0.919 ln(f1 f2 )

(4)

- 4.3 N ssbond - Gref
where Scontact, Voverlap, Ehbond, Eelec, ΔSpho, and ΔSphi represent atom-contact surface area,
overlap, H-bond energy, electrostatic interaction energy, buried hydrophobic solvent
accessible surface, and buried hydrophilic solvent accessible surface between the rotamer
of residue i and the rest of protein, respectively. Fphi, Vexclusion, Nssbond, and ΔGref are
defined as the fraction of the buried surface of non-hydrogen-bonded hydrophilic atoms,
the normalized solvent exclusion volume around charged atoms, the flag of disulfide
bridge(1 or 0), and the difference between the free energy of the rotamer in solvent and
denatured protein, respectively. f1 is the observed frequency of the rotamer and f2 is the
observed frequency of the amino acid residues in a given backbone conformation.
d) Contact number
The residue contact number is the number of Cα atoms in the antigen within a
distance of 10 Å of the Cα atom of residue i (8). A residue with a small contact number
was considered as an antibody binding site residue.
e) Surface planarity score
The planarity of each surface patch was calculated by evaluating the root mean
squared deviation (rmsd) of all the Cα atoms in the surface patch from the least squares
plane through the atoms. The rms deviations were inverted such that a high planarity
score for a patch was interpreted as a planar patch and antibody binding site (20).
f) Secondary structure composition
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This score was defined as the fraction of patch residues forming turns or loops in
all 20 patch residues. Based on Chou and Fasman's method (21), the α-helix and β-sheet
were defined as four or more consecutive residues having φ and ψ angles within 40° of (60°, -50°) and three or more residues having φ and ψ angles within 40°of (-120°, 110°)
or (-140°, 135°), respectively. The remaining regions were considered turns and loops.
2.3 Training Procedure for EPSVR
For each surface patch, the number of epitopic residues could be any integer value
between 0 and the patch size (20 for this study), and each surface patch had six Support
Vector Regression (SVR) attributes as described above. The residue epitope propensity,
conservation score, and side-chain energy score were calculated at the residue level and
averaged over all residues in the patch. The six scores and the number of observed
epitopic residues in the patch were scaled to 0~1.
All SVR parameters were optimized by a grid search (c = 2-10~-1, g = 2-12~-3, and p
= 2-5~-2) where c is trade-off between training error and margin, g is parameter gamma for
radial basis function kernel, and p is the fraction of unlabeled examples to be classified
into the positive class (22); and for each grid point of triplets, a leave-one-out procedure
was applied to evaluate the trained SVR model. Specifically, the patch score of each
surface patch for a target in the training set was predicted by the SVR model trained with
the other 47 antigen-antibody complexes, from which the residue epitope propensity
score was also derived. After this procedure was repeated 48 times, the mean AUC value
of 48 predictions represents the performance of the current grid point for SVR parameters.
The triplet of parameters that reached the highest value of mean AUC was chosen and
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used for the test set, and the final support vector machine model was trained with all 48
targets.
2.4 Prediction Procedure for EPSVR
A surface patch is defined as a central surface residue and its 19 nearest surface
neighbors in space, where a surface residue is defined if the relative accessibility of its
side chain is greater than 6% with probe radius = 1.2Å. First, we searched for all surface
residues and enumerated all surface patches of a given antigen structure, and calculated
their six SVR attributes. For each surface patch, we predicted the number of putative
epitopic residues by the trained SVR model. Here, a patch score was defined as the
fraction of the number of putative epitopic residues to the total number of amino acid
residues in the patch, i.e., 20. One surface residue was assigned a residue score by
averaging patch scores of all patches in which this amino acid residue is included. Finally,
we sorted surface residues according to their residue scores and the top-ranked ones were
considered as epitopic residues. The assumption here is that a residue frequently
appearing in top- scoring patches is likely an epitopic residue.
Patch analysis was used in all existing B-cell discontinuous epitope studies. In the
examples of EPCES and EPITOPIA, a patch score was derived by averaging the scores
of all residues in the patch, and the central residues of top scored patches were predicted
as epitopic residues. However, the value of the patch score was actually correlated with
the number of epitopic residues in the patch rather than the central residue. Here, we used
SVR to predict the number of epitopic residues in a surface patch and residues frequently
located in the top scored patches were predicted as epitopic residues. For this case, the
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SVR model is more suitable than a support vector classifier. In this study, we used an
SVR package, called LIBSVM, obtained from http://www.csie.ntu.edu.tw/~cjlin/ libsvm.
2.5 Results
2.5.1 Prediction for the Training Set for EPSVR
When c=2-6, g=2-5, p=2-3, the mean value of AUC for the 48 targets in the training
set reached its maximum, 0.670, in the leave-one-out test. As a comparison, the mean
AUC value is 0.644 predicted by EPCES, whose residue interface propensity was derived
from the other 47 targets using the same leave-one-out procedure as described. The
improvement of EPSVR could be attributed to the machine learning method because
EPSVR and EPCES used the same six scoring terms. In another study, Rubinstein et al.
applied support vector classifier (EPITOPIA) to predict B-cell epitopes and obtained a
mean AUC value of 0.65 for a similar non-redundant set of 47 antigen-antibody complex
structures in cross validation (13). Our algorithm showed slightly better performance for
a somewhat different training set.
2.5.2 Prediction for the Test Set for EPSVR
We applied our algorithm, with the optimally trained parameters, to the
independent test set, and achieved a mean AUC value of 0.597, which was lower than
that of the training set. Nevertheless, 6 out of 19 targets were predicted with an AUC
value greater than 0.7. Note that the interface residues of antigens in the test set were
identified by point mutations, overlapping peptides, and ELISA, which are not as
accurate as the crystal complex structure method.
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Six antigens in test proteins (1eku, 1av1, 1al2, 1jeq, 2gib, and 1qgt) contained
multiple chains, but we only used a single chain where the experimental antigenic epitope
was located for prediction. If the whole protein was used for prediction, the mean AUC
value of the six proteins decreased from 0.672 to 0.623. Unlike antigenic epitopes, the
interfaces of protein-protein complexes, especially non-transient complexes, are usually
more hydrophobic and conserved than protein surfaces; it makes the exposed proteinprotein interfaces relatively-easily distinguishable from both the antigenic epitopes and
other protein surfaces. In other words, a single chain protein that has both protein-protein
binding interfaces and epitope made the epitope prediction task easier.
3. Development of Conformational B-cell Epitope Meta Tools EPmeta
3.1 Selection of Conformational B-cell Epitope Prediction Tools
Selection of conformational B-cell epitope prediction tools is a key step in
constructing the meta server. Before EPSVR, there were only a limited number of
methods available, i.e., CEP (7), DiscoTope (8), PEPITO (9), ElliPro (10), SEPPA (11),
EPITOPIA (12, 13), and EPCES (4). These tools applied different physicochemical
properties of epitopes in their corresponding model-training, such as the hydrophilicity
scale and the epitope log-odds ratios in DiscoTope (8), the epitopic residue propensity
and the half sphere exposure values at multiple distances in PEPITO (9), residue
protrusion index (PI) in ElliPro (10), the epitopic residue propensity and the compactness
of the neighboring residues around one residue in SEPPA (11), forty-four
physicochemical and structural–geometrical attributes in EPITOPIA (12, 13), and six
physicochemical properties used in EPCES (4) and EPSVR (23). These attributes have
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different effects on determining conformational B-cell epitopes. Hence, in our EPmeta
server, different servers should have different weights in constructing the consensus
result.
3.2 The Architecture of EPmeta
An open question for any meta server is how to quickly obtain prediction results
from multiple tools. One choice is install these tools locally. Local installation requires
standalone packages. Unfortunately, DiscoTope (8), PEPITO (9), ElliPro (10), SEPPA
(11), or EPITOPIA (12, 13) cannot provide a standalone package for local installation.
With the idea of remote searching technology, a machine-simulation will obtain
the searching results on web browser through accessing remotely available servers. In
contrast to using locally installed programs, a meta server can directly access to remotely
available services, run a query, and download the results from the remote servers. This is
the strategy used for EPmeta.

Figure 3.1 Architecture of the EPmeta server.
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3.3 The programming technologies to complete the EPmeta server
The main technological blockage in using remote servers is how to communicate
between the meta server and other online tools. Unfortunately, we solved this issue by
carrying out a type of machine-simulation of automated web-browser navigation. Scripts
can automate completing a series of customized operations on web browsers, such as to
open a web browser, input a Uniform Resource Locator (URL) address, fulfill the form
on web page, upload a PDB file (3D protein structures), and download a web source page.
All the operations including human-like activities with mouse and keyboard in front of a
computer are simulated. Hence, the meta server does not need an API or a web server to
communicate with online tools. It just relies on the successful access to the remote
servers by a web browser, such as Internet Explorer or Firefox.
There are many ways to carry out machine-simulated automated navigation of a
web browser. Similar technologies are applied on automated testing during the
development of web applications. To decrease human labor on repeated software testing,
software development engineers in testing (SDET) developed the platform of automated
testing. For automated testing of web applications, machine-simulated navigation of a
web browser is one of the fundamental functions of the platforms. Although many such
automated testing platforms are commercial products, there are a few open-source free
platforms on Microsoft Windows with Internet Explorer and fewer on Linux with Firefox.
In this study, we chose a platform based on a programming language Ruby and the Watir
platform to our EPmeta. Watir is an open-source free platform providing the Ruby library
for automating web browsers (http://watir.com/). Using Ruby and Watir, we completed
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the automated access of online tools by our meta sever and achieved the query on these
tools.
Figure 3.1 illustrates the architecture of the EPmeta server. We choose the six
tools because their reports showed the best predictions when we prepared EPmeta server
in 2009. After completing six queries to EPSVR, EPCES, EPITOPIA, SEPPA, PEPITO,
and Discotope1.2, we generate a consensus result.
For the Meta server, the basic idea was that a surface residue is predicted as an
epitopic residue if two or more single servers voted for it. In this naive sense, the mean
AUC values of the 19 testing proteins was calculated to be 0.562, 0.618, 0.627, 0.621,
and 0.612 predicted by the top 2, 3, 4, 5, and 6 servers, respectively (Table 3.1). To adopt
a more sophisticated strategy, the top 25% of surface residues were returned as predicted
epitopic residues by EPSVR, EPCES, and EPITOPIA. When the number of the predicted
residues was increased from 25% to 50%, from 50%to 75%, and from 75% to 100%,
SEPPA, PEPITO, and DiscoTope1.2 were, respectively, included in the voting. For
example, the new antigenic residues predicted by EPSVR, EPCES, EPITOPIA, and
SEPPA were added to the top 25% residues predicted by EPSVR, EPCES, and
EPITOPIA. The prediction started with 1% of the surface residues for each of the four
servers and increased insteps of 1% until 50% of surface residues were predicted as
antigenic residues. Then we added PEPITO and used five servers to predict the top
50%~75% surface residues and so on. With this method, we achieved a mean AUC value
of 0.638, which is higher than all single servers, especially, Discotope1.2 and PEPITO (pvalue < 0.05). The reason that we used this strategy to integrate the various predictions
results from our finding that a single server had better prediction accuracy when only a

70
small fraction of the surface residues were predicted as epitopic residues. If 50% of
surface residues, for example, were predicted as epitopic residues by the Meta server, the
prediction accuracy was 14.4% for the Meta server with a voting set including EPSVR,
EPCES, and EPITO-PIA, where each server output the top 51% surface residues as
candidates of antigenic residues. As a comparison, the prediction accuracy was slightly
higher (15.3%), if the Meta server also returned 50% of the surface residues as epitopic
residues, but got votes for those returned residues from all of the six servers, where each
server output their own top 32% surface residues as candidates of epitopic residues.
The following is the final algorithm:
[
BEGIN
N = the total number of surface residues;
E = the number of predicted epitopic residues;
if E ≤25% * N then,
return Predictor (0, E, EPSVR, EPCES, EPITOPIA);
else if E > 25%*N AND E ≤50%*N then,
return Predictor (R25, E, EPSVR, EPCES, EPITOPIA, SEPPA);

// Rp = p% of surface

residues already predicted as epitopic residues;
else if E > 50% AND E ≤75%*N then,
return Predictor (R50, E, EPSVR, EPCES, EPITOPIA, SEPPA, PEPITO);
else if E > 75% AND E ≤100%*N then,
return Predictor(R75, E, EPSVR, EPCES, EPITOPIA, SEPPA, PEPITO, Discotope1.2)
endif.

Function Predictor(Rp,E,SERVER1,SERVER2,SERVER3,...)
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Begin
set the prediction of each single server to 0;
do {
Increase the prediction of each single server at the step of 1%;
Collect residues predicted by at least two of the servers;
} While(Rp + collected epitopic residues other than Rp < E);
Return total epitopic residues;
END
]

3.4 Results
Although EPSVR and EPCES used the same six scoring terms, we found that it
was necessary to include both of them in the Meta server. When we used a voting server
set including EPCES, EPITOPIA, and SEPPA, i.e. excluding EPSVR, the average AUC
value decreased to 0.587 for the test set. The average AUC value predicted by EPSVR,
EPITOPIA, and SEPPA (0.611) was also lower than that predicted by EPSVR, EPCES,
and EPITOPIA in the standard procedure (0.618). We also tried to increase the threshold
of votes from two to three for a voting server set, but the results did not improve.
4. Discussions
We introduced a SVR method to integrate six attributes for discontinuous epitope
prediction and a server, EPSVR, which can be accessed online. The AUC of EPSVR is
0.597, which is higher than that of any other existing single server. Although they used
the same scoring functions, EPSVR exhibited improved performance over EPCES. This
was attributed to the fact that EPSVR searched the six-dimensional parameter space of all
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scores more broadly than the voting method we previously used. Furthermore, a Meta
server, EPmeta, combining EPSVR and the other existing single servers together, had an
AUC value of 0.638, which is higher than any single server, especially, DiscoTope and
PEPITO. We also found that the use of both EPSVR and EPCES, which use the same 6
scoring terms, resulted in a higher performance for EPmeta than if only one was used.
The AUC results for different methods are shown in Table 3.1.
Table 3.1 List of the Conformational B-cell Epitope Prediction Methods and Their
Obtained AUC Results
Method

URL of web server

AUC

Accuracyb
(%)

DiscoTope (8)

http://www.cbs.dtu.dk/services/DiscoTope/

0.567

15.5

BEpro(PEPITO) (9)

http://pepito.proteomics.ics.uci.edu/

0.570

17.0

ElliPro (10)

http://tools.immuneepitope.org/tools/ElliPro/iedb_input

0.585

14.3

SEPPA (11)

http://lifecenter.sgst.cn/seppa/index.php

0.576

17.2

EPITOPIA (12, 13)

http://epitopia.tau.ac.il/index.html

0.579

17.8

EPCES (4)

http://sysbio.unl.edu/EPCES/

0.586

18.8

EPSVR (23)

http://sysbio.unl.edu/EPSVR/

0.597

24.7

Bpredictor (14)

http://code.google.com/p/my-projectbpredictor/downloads/list

0.598a

24.0c

http://sysbio.unl.edu/EPmeta/
EPmeta (23)
0.638
25.6
a)
b)
The AUC value is obtained from the Reference (14). 10% of surface residues are
returned as predicted epitopic residues. c) Estimated based on the Figure 4 in the
Reference.

To assess and compare prediction performance of these predictors, we carried out
an independent test by the testing set containing 19 protein monomer structures with
epitope information derived from experimental methods other than crystal structures.
AUC score is the major criterion for each method. A receiver operating characteristic
(ROC) curve represents a dependency of true positive rates (sensitivity) and false positive
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rates (1-specificity), plotted at various thresholds. To change the thresholds, the number
of predicted residues is increased in steps of 1% of total surface residues. The mean AUC
values are calculated using a java program available at
http://pages.cs.wisc.edu/~richm/programs/AUC/ (24), except for Bpredictor. For
Bpredictor, the AUC value is directly obtained from the manuscript (14) where the same
benchmark by Liang et al. (4) was applied as in the current work. Among single servers,
EPSVR and Bpredictor have the best performance according to the AUC values.
Although EPSVR has the highest mean AUC value, the differences between EPSVR and
other servers are not statistically significant (p-value >0.05), according to the pairwise tstudent tests. The Meta server, EPmeta, achieves a mean AUC value of 0.638, which is
significantly higher than all single servers.
We also calculated the accuracy by the same independent test because the
accuracy, i.e. positive prediction rate, is useful for experimental testing. When each
server returns 10% of surface residues as predicted epitopic residues, the accuracy was
14.3%, 15.5%, 17.0%, 17.2%, 17.8%, 18.8%, 24.7%, and 25.6% for Ellipro,
DiscoTope1.2, BEpro (PEPITO), SEPPA, EPCES, EPITOPIA, EPSVR, and EPmeta,
respectively, as shown in Figure 3.2. The accuracy is around 24% for Bpredictor based
on Figure 4 in the Reference (14). The rationale of selecting 10% surface residues to be
predicted as positive is because the average length of antigen proteins is around 200
amino acids and the average size of epitopic patch is about 20 amino acid residues. The
current level of accuracy of all predictors is not yet satisfactory. Even the highest
accuracy, 25.6% achieved by EPmeta, leaves room for further improvement. If 3% of

74
surface residues are returned as predicted epitopic residues, the accuracy of EPmeta is
31.6%, which is the overall highest value by all conditions and methods.

Figure 3.2 Prediction accuracy of six antigenic epitope prediction servers and Meta
server on 19 independent testing proteins. Y-axis is AUC score and x-axis is the
threshold of prediction score. The prediction accuracy was averaged for 19 independent
testing proteins, except for EPITOPIA because it failed to assign scores for the antigenic
residues of 1jeq and the prediction accuracy was averaged over the other 18 proteins.
For the EPmeta server, its architecture of using remote web servers lowers the
pressure of the local meta server. The computational time is mainly based on the speed of
online tools and the transferring speed throughout the internet. While with steady internet
connection, communication between the meta server and online tools is no longer an
issue, computational time with each online tool is the major time consuming part. Most of
conformational B-cell epitope prediction tools require more than ten minutes, even half
an hour, to complete one query for 200-aa sequence. For example, the average computing
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time for EPITOPIA is over thirty minutes based on our tests accessing from the
University of Nebraska – Lincoln. The distributed architecture of the meta server allows
the parallel operations involved in multiple queries to different online tools. Therefore,
unlike local implementation of different tools, we can run these queries online
simultaneously and we do not have to care about the machine pressures since these online
servers are independent. Distributed system has been widely applied for large-scale or
intensive computation, usually shared among multiple physical machines.
This distributed architecture also lowers the risk of the EPmeta server for
installation and maintenance of multiple programs. Since we did not intend to install the
tools locally, proper installation was not an issue. It is also easier to track the newest
version of tools by just accessing them directly online. As a result, the distributed
architecture of the meta server guarantees always the good query of results from different
tools.
5. Challenge of Conformational B-cell Epitope Prediction
In recent years, a number of new conformational B-cell epitope prediction
algorithms have been developed. While the prediction performance has been improved, it
is still far from satisfactory. Compared with other bioinformatic problems, antigenic
epitope prediction is especially difficult due to the lack of properties that are universally
but uniquely observed for the antigenic epitopes but not for other protein surfaces.
Additionally, regular binding-site prediction methods are not suitable for antigenic
epitope prediction because they focus on the conservation of surface residues.
5.1 Single Chain or Multiple Chains
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The recognition of antibody to antigenic epitopes has high specificity; the epitopic
surface is not as conserved as other functional protein binding sites, which comes from
the conserved functions of protein-protein interactions during evolution. The interfaces of
regular protein-protein binding are usually more conserved and have more hydrophobic
amino acid residues than non-binding protein surfaces. This makes the exposed proteinprotein interfaces relatively easy to distinguish from both the antigenic epitopes and nonbinding protein surfaces. In other words, the prediction task for a single chain protein that
has both protein-protein binding interfaces and an antigenic epitope is easier than that of
a protein complex.
In the benchmark dataset, six of the proteins (PDB IDs: 1eku, 1av1, 1al2, 1jeq,
2gib, and 1qgt) possess multiple chains. Therefore, in our evaluation all methods were
tested with two different scenarios for these six proteins: prediction on a single chain
where the experimental antigenic epitope is located and prediction on the whole protein
including all chains. When multiple chains were examined, all chains were considered,
and the total number of surface residues was counted for the intact complex structure. As
a result, some methods, such as EPSVR, showed decreased performance with lower mean
AUC values for the 6 proteins when the whole protein was used for prediction compared
with those based on the single chain containing the antigenic epitope. Therefore, in the
future, if sufficient data exist, a range of test datasets shall be compiled for different cases,
i.e., single chain antigens, single chains from antigen complexes, and antigen complexes.
A good antigenic epitope predictor shall have satisfying performance on all types of
benchmarks.
5.2 Protein Binding Site Prediction Methods
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Due to the lack of many epitope prediction methods for analysis and comparison,
potein-binding site prediction methods are frequently used for conformational epitope
prediction (5, 25) since epitopic patches can be considered as a type of protein binding
sites. The methodologies used by protein binding site prediction and epitope prediction
are similar; both integrate some amino acid scoring functions with a machine learning
algorithm or other platform to train a prediction model on known data. The major
difference is their distinct training sets; while protein binding site prediction uses all
known protein-protein binding complexes, an epitope prediction method is trained with
antibody-antigen complexes only. Therefore, we also applied the benchmark epitope
dataset to test some binding site prediction methods. For this we selected binding-site
prediction methods that have both demonstrated good performance and convenient web
servers for public use. The AUCs achieved by these methods for the epitope benchmark
are shown in Table 3.2. One can see that the performances of the binding-site prediction
methods to predict B-cell epitopes are significantly lower than all conformational epitope
prediction methods (shown in Table 3.1). This is not surprising because all binding-site
prediction methods are designed based on the conservation and hydrophobicity of
binding patches. B-cell epitopic patches are neither conserved nor more hydrophobic
compared with other protein-protein binding surfaces. Instead, the residues on the
antigenic epitopes are more diverse than regular surface residues due to the evolution
pressure from the host immune system. Therefore, we conclude that the general bindingsite prediction methods are not suitable for antigenic epitope prediction. Any epitope
prediction methods developed in the future is not recommended to claim performance
improvement by simply compared with binding-site prediction methods.
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Table 3.2 List of the Protein Binding Site Prediction Methods and Their Obtained
AUC Results
Method

URL of web server

AUC

ProMate (26)

http://bioinfo.weizmann.ac.il/promate/

0.530

ConSurf (27)

http://consurf.tau.ac.il/index_proteins.php

0.460a

PINUP (17)

http://sysbio.unl.edu/services/PINUP

0.562

PIER (28)
http://abagyan.ucsd.edu/PIER/pier.cgi?act=dataset 0.537
Conserved residues are selected as for common binding site prediction.

a)

5.3 Future Directions
Currently, various sets of attributes and classifiers have been applied by different
existing epitope prediction algorithms. It naturally leads to one question: which
combination of attributes is optimal for the prediction? To answer this question, one may
systematically evaluate different machine-learning algorithms on all non-redundant
attributes and allocate the optimal set among them. Also of great importance to the
epitope prediction research is the growth of the training data, especially the antigens that
have both bounded and unbounded structures. It is also important to collect high quality
independent testing data, such as the ones compiled by Liang et al. (23), that contain
experimentally measured epitopic residues but no complex structures. We also
recommend that all future researchers implement their developed algorithms as free
accessible web servers or downloadable software packages, because B-cell epitope
prediction algorithms will likely become more and more complicated and meta-methods
usually have better prediction accuracy than any of the single algorithms.

79
REFERENCES
1.
2.
3.

4.
5.
6.
7.
8.

9.

10.

11.

12.
13.
14.

15.

16.
17.

Lefkovits, I., Jerne, N. K., Steinberg, C. M., and Di Lorenzo, C. (1981) The
Immune system, Karger, Basel ; New York.
Reineke, U., and Schutkowski, M. (2009) Epitope mapping protocols, 2nd ed., pp
1 online resource (xiii, 456 p., [416] p. of plates), Humana Press, New York.
Bernstein, F. C., Koetzle, T. F., Williams, G. J., Meyer, E. F., Jr., Brice, M. D.,
Rodgers, J. R., Kennard, O., Shimanouchi, T., and Tasumi, M. (1977) The Protein
Data Bank. A computer-based archival file for macromolecular structures,
European journal of biochemistry / FEBS 80, 319-324.
Liang, S., Zheng, D., Zhang, C., and Zacharias, M. (2009) Prediction of antigenic
epitopes on protein surfaces by consensus scoring, BMC bioinformatics 10, 302.
Ponomarenko, J. V., and Bourne, P. E. (2007) Antibody-protein interactions:
benchmark datasets and prediction tools evaluation, BMC structural biology 7, 64.
Walter, G. Production and use of antibodies against synthetic peptides, Journal of
Immunol. Methods. 1986;88:149–61. doi: 10.1016/0022-1759(86)90001-32.
Kulkarni-Kale, U., Bhosle, S., and Kolaskar, A. S. (2005) CEP: a conformational
epitope prediction server, Nucleic acids research 33, W168-171.
Haste Andersen, P., Nielsen, M., and Lund, O. (2006) Prediction of residues in
discontinuous B-cell epitopes using protein 3D structures, Protein Sci 15, 25582567.
Sweredoski, M. J., and Baldi, P. (2008) PEPITO: improved discontinuous B-cell
epitope prediction using multiple distance thresholds and half sphere exposure,
Bioinformatics (Oxford, England) 24, 1459-1460.
Ponomarenko, J., Bui, H. H., Li, W., Fusseder, N., Bourne, P. E., Sette, A., and
Peters, B. (2008) ElliPro: a new structure-based tool for the prediction of antibody
epitopes, BMC bioinformatics 9, 514.
Sun, J., Wu, D., Xu, T., Wang, X., Xu, X., Tao, L., Li, Y. X., and Cao, Z. W.
(2009) SEPPA: a computational server for spatial epitope prediction of protein
antigens, Nucleic acids research 37, W612-616.
Rubinstein, N. D., Mayrose, I., Martz, E., and Pupko, T. (2009) Epitopia: a webserver for predicting B-cell epitopes, BMC bioinformatics 10, 287.
Rubinstein, N. D., Mayrose, I., and Pupko, T. (2009) A machine-learning
approach for predicting B-cell epitopes, Molecular immunology 46, 840-847.
Zhang, W., Xiong, Y., Zhao, M., Zou, H., Ye, X., and Liu, J. Prediction of
conformational B-cell epitopes from 3D structures by random forests with a
distance-based feature, BMC bioinformatics 12, 341.
Mintseris, J., Wiehe, K., Pierce, B., Anderson, R., Chen, R., Janin, J., and Weng,
Z. (2005) Protein-Protein Docking Benchmark 2.0: an update, Proteins 60, 214216.
Huang, J., and Honda, W. (2006) CED: a conformational epitope database, BMC
immunology 7, 7.
Liang, S., Zhang, C., Liu, S., and Zhou, Y. (2006) Protein binding site prediction
using an empirical scoring function, Nucleic acids research 34, 3698-3707.

80
18.

19.
20.
21.
22.

23.

24.

25.
26.

27.

28.

Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W.,
and Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs, Nucleic acids research 25, 3389-3402.
Liang, S., and Grishin, N. V. (2004) Effective scoring function for protein
sequence design, Proteins 54, 271-281.
Jones, S., and Thornton, J. M. (1997) Analysis of protein-protein interaction sites
using surface patches, Journal of molecular biology 272, 121-132.
Chou, P. Y., and Fasman, G. D. (1978) Empirical predictions of protein
conformation, Annual review of biochemistry 47, 251-276.
Joachims, T. (1999) Making Large-Scale SVM Learning Practical, Advances in
Kernel Methods - Support Vector Learning, B. Scholkopf and C. Burges and A.
Smola (ed.), MIT-Press.
Liang, S., Zheng, D., Standley, D. M., Yao, B., Zacharias, M., and Zhang, C.
EPSVR and EPMeta: prediction of antigenic epitopes using support vector
regression and multiple server results, BMC bioinformatics 11, 381.
Davis, J., and Goadrich, M. (2006) The Relationship Between Precision-Recall
and ROC Curves, 23rd International Conference on Machine Learning (ICML),
Pittsburgh, PA, USA, 26th - 28th June.
El-Manzalawy, Y., and Honavar, V. Recent advances in B-cell epitope prediction
methods, Immunome research 6 Suppl 2, S2.
Neuvirth, H., Raz, R., and Schreiber, G. (2004) ProMate: a structure based
prediction program to identify the location of protein-protein binding sites,
Journal of molecular biology 338, 181-199.
Ashkenazy, H., Erez, E., Martz, E., Pupko, T., and Ben-Tal, N. ConSurf 2010:
calculating evolutionary conservation in sequence and structure of proteins and
nucleic acids, Nucleic acids research 38, W529-533.
Kufareva, I., Budagyan, L., Raush, E., Totrov, M., and Abagyan, R. (2007) PIER:
protein interface recognition for structural proteomics, Proteins 67, 400-417.

81

CHAPTER FOUR: PREDICTION OF EPITOPIC RESIDUES WITH
PROTEIN SEQUENCES
1. Introduction
In the previous chapters, we discussed the two kinds of B-cell epitopes: linear and
conformational epitopes. It was reported that about 90% B-cell epitopes are
conformational (1). Therefore, we developed prediction tools for conformational epitopes
based on known 3D structures of given antigens. However, the small number of solved
structures of antigens limits the application of our epitope prediction. In this chapter, we
will tackle this difficulty by developing a new method to analyze antigen protein
sequences to predict epitopic residues. Currently the study on protein-sequence-level
prediction of epitopic residues of B-cell epitope is still under development. One possible
reason is a limited resource of known epitopic residues of B-cell epitope. Another reason
lies in the complexity of epitope binding patterns. At present, to our knowledge, there are
a very few epitope-antibody binding patterns reported. So it is still difficult to extract the
principles of key residues from known epitope-antibody binding patterns. Due to these
facts, we must find a new way to predict the key residues of B-cell epitopes.
In chapters two and three, machine learning methods have been proven powerful
in terms of classification. By the analysis of known B-cell epitopes and non-epitopes, a
machine learning method draws a border to separate epitopes and non-epitopes. In this
chapter, we will apply the Support Vector Machine (SVM) as a tool of machine learning
to predict epitopic residues based on input of protein sequences.
To set up a training process, the first step is to collect known epitopic residues of
B-cell epitopes. The immune epitope database (IEDB) contains the updated information
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of B-cell epitopes most of which are still hypothetical (2). For our study, we employ a
more reliable way to collect key epitopic residues of antigens. In our study only 3D
structures of antigen-antibody complexes precisely showing the residues of epitope
directly bound to antibody are used as the data resource. To construct the positive dataset,
we have investigated 561 antigen-antibody complexes whose antigens come from 11
species. For these antigen sequences, we filtered them by a threshold of 30% similarity to
generate an unbiased dataset. After the similarity filtering, we extracted 2682 key
residues which come from 134 unique antigens. The details about building the positive
dataset containing known key epitopic residues are described in section 2.1.
For each epitopic residue, the subsequence surrounding it with a certain length is
extracted from the original antigen, and the sequence pattern and physicochemical
characteristics of any given subsequence are quantified for epitopic residue prediction.
The sequence pattern and physicochemical properties of these segments include Shannon
Entropy (SE), Relative Entropy (RE), Position Specific Scoring Matrix (PSSM),
Predicted Secondary Structure (SS), Protein Disorder (DIS), Solvent Accessible Area,
Overlapping Properties (OP), Sequence Complexity (SC), and Averaged Cumulative
Hydrophobicity (ACH). They are considered and optimized as the segment features for
SVM training in our study. Similar strategy and features can also be applied to the point
residue prediction, such as the prediction of phosphorylation sites (3, 4).
In this study, we developed a novel tool, named SVMKER, to predict the epitopic
residues with an input of a protein sequence only. With carefully designed feature
characterization of the sequence segments, SVMKER has shown a precision of 59.5%
and a sensitivity of 52.2% using five-fold cross-validation process. It is the first time that
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a prediction tool has been developed for epitopic residue prediction at the protein
sequence level. This tool can provide a preliminary search for epitopic residues on
antigens before an experimental design.
2. Materials and Methods
2.1 Datasets
The original information about epitopic residues of B-cell epitopes was extracted
from PDB (5). As of June 2012, we downloaded 561 3D structures of antigen-antibody
complexes involved in 11 species. From these 3D structures, we extracted 134 lowsimilarity antigen sequences with a threshold of 30% similarity. An amino acid residue of
the antigen is considered as one epitopic residue if it has at least one atom that has less
than 6 Å distance to any atom of antibody (6). The criterion is illustrated with an example
in Figure 4.1 below.

Figure 4.1 The distance of atom-atom distance between antigen and antibody. The
epitopic residue on an antigen must contain at least one atom with less than 6 Å distance
away from an antibody‟s atom. For example, in the 3D structure of human IgM
rheumatoid factor Fab bound to its autoantigen IgG Fc (PDB ID: 1ADQ) (7), the amino
acid residue ASN-384 is considered as an epitopic residue because it contains two atoms
less than 6 Å from the antibody. The same happens to GLN-386.

84

After identifying all known epitopic residues from the 3D structures of the
antigen-antibody complexes, we created the positive datasets containing 2682 protein
sequence segments with epitopic residues in the middle positions. The segment length
includes 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, and 23 amino acids (AA). Figure 4.2 shows
protein sequence segments with different sizes. The negative dataset was constructed by
including the non-redundant segments with the same length of positive dataset segments
from the sections of antigen sequences where no epitopic residues exist. The total
numbers of positive and negative segments are 2682 each; the positive and negative
segment ratio is 1:1.

Figure 4.2 A segment in the positive dataset determined by extending the key
epitopic residue in both sides along the antigen sequence.

2.2 Attributes
For a machine-learning technology, we need to quantify the sequence pattern and
physico-chemical properties of these protein segments in the training set. We used
multiple attributes including Shannon Entropy (SE), Relative Entropy (RE), Position
Specific Scoring Matrix (PSSM), Predicted Secondary Structure (SS), Protein Disorder
(DIS), Solvent Accessible Area, Overlapping Properties (OP), Sequence Complexity
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(SC), and Averaged Cumulative Hydrophobicity (ACH). The details of calculation for
these attributes are described in the following sections.
2.2.1 Shannon Entropy (SE)
SE score, a widely used sequence conservation measure, is calculated by
weighted observed percentages (WOP) extracted from the results of PSI-BLAST (8) with
Non-redundant protein sequence database. The WOP vector for a position in a given
protein sequence shows the position-specific distribution of 20 amino acids. The SE score
for the given position is defined as:
20

SE   pi log  pi  ,

(1)

i 1

where pi=ai/Σaj, aj is the j-th value in the WOP vector for this given position. If a
position has complete conservation, the SE score has the smallest value, 0.
2.2.2 Relative Entropy (RE)
RE measures the amino acid background distribution, and also requires the WOP
matrix. The RE score of one type of amino acids is calculated as:
20
p 
RE   pi log i  ,
i 1
 p0 

(2)

where pi =ai/Σaj, aj is the j-th value in the WOP vector for this given position and p0
is the protein BLOSUM62 background distribution.
2.2.3 Position Specific Scoring Matrix (PSSM)
PSSM is commonly used for the representation of motifs or patterns in biological
sequences. To identify the pattern of neighbors besides key epitopic residues, we
calculated the PSSM matrix using the BLASTP tool. PSSM can provide 20 bits for vector
features.
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2.2.4 Secondary Structure (SS)
The most accurate way to obtain the information of secondary structures would be
from the 3D structures of proteins. However, for a given protein sequence, the secondary
structures can only be predicted. In this chapter, the SS attribute of each residue has three
bits to show the possibility scores of three types of secondary structures (H: helix, E: βsheet, and C: coiled coil ) which is predicted by PSIPRED (9).
2.2.5 Protein Disorder (PD)
PD is important for protein function. Previous works suggest that protein disorder
information is helpful to improve the discrimination between active sites and non-active
sites (10). In our study, protein disorder areas are predicted by DISOPRED (11). The
prediction result provides a score for each residue between 0 and 1, corresponding to
more structured to more disordered status.
2.2.6 Accessible Surface Area (ASA)
All epitopic sites are on the surface of an antigen, and hence, large solvent
accessibility is also an important feature of the catalytic residues. To improve the
prediction accuracy, the solvent ASA information of each residue is included into the
algorithm as well. The ASA attribute needs to be predicted from protein sequences. In
our study, RVP-net is used to predict the relative solvent ASA for each residue in a given
protein sequence (12). Each residue has a real value in (0, 1) for the ASA attribute.
2.2.7 Averaged Cumulative Hydrophobicity (ACH)
ACH has been demonstrated to be an important attribute for protein functional
residues. The attribute is quantified by computing the average of the cumulative
hydrophobicity indices over the segment sizes of 3, 5, 7, ... , 21, and 23AA. There are
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ACH scores for 10 bits in the feature vector. The hydrophobicity index proposed by
Sweet and Eisenberg is used in this chapter (13).
2.2.8 K-nearest neighbor profiles (KNN)
KNN usually is applied in the prediction of active sites, such as phosphorylation
sites (4). A KNN score for one given sequence is the proportion of positive key epitopic
residue in its k nearest neighbors in the training set where the distance between the two
sequences is proportional to their sequence similarity; a pair of similar sequences has a
short distance. The parameter k of KNN is set as 0.25%, 0.5%, …, and 5.and the KNN
profile attribute has 20 bits.
2.3 Training and Five-fold Cross Validation
The training process is based on the Support Vector Machine tool, SVMlight (14).
The kernel function used is the radial basis function, exp(-γ||a-b||2). To obtain the optimal
training performance, we did a grid searching in the range of (c=2-10~1, g =10-8~0, and
p=2-5~0) where c is the trade-off between training error and margin, g is the parameter γ in
the radial basis function kernel, and p is the fraction of unlabeled examples to be
classified into the positive class. For each segment length of the training dataset, the grid
searching was independently executed and completed for different optimal parameter sets.
Five-fold cross-validation is executed for SVM training in the absence of an
independent testing set. We first split the training dataset into five subgroups with the
same size. Each group contains the same number of positive segments (epitopic residue
inside) and negative segments (non-epitopic residue) as any other fold. During the
procedure of making five groups, we make sure that a segment has more similarity with
sequences in the same group than one from other group. The segments with more
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sequence similarity are grouped in the same fold, which can significantly reduce the
potential bias in the validation. During the five-fold cross-validation process, in turn the
four folds are used to calculate the model and the last one is to evaluate the accuracy of
the model calculated.
The related statistical evaluation is listed below,

TP
´100%
TP+FN
TP
Pre =
´100%
TP+FP
2 ´ Pre ´ Sen
F=
,
Pre+Sen

Sen =

where TP, TN, FP, and FN stand for true positive, true negative, false positive, and false
negative, respectively. All of calculations above are based on five-fold cross-validation
procedure. We also generated the receiver operating characteristic (ROC) curve for
statistical evaluation of SVMKER. In the ROC curve, false positive rate, i.e. FPR = FP /
(FP + TN), is x-axis while sensitivity (Sen or true positive rate, as shown above), is yaxis. Area under the curve (AUC) has been widely accepted as a performance index, with
a higher AUC score representing a higher prediction performance. A java program
available at http://pages.cs.wisc.edu/~richm/programs/AUC/ was used to calculate the
AUC (15).

3. Results
The length of segments extending from epitopic residue will greatly impact the
prediction. The shorter lengths, such as 3, 5, and 7AA, are difficult to generate a stable
prediction performance. In current version of SVMKER, the eight attributes were applied,
and they are SE (1 bit), RE (1 bit), PSSM (20 bits), SS (3 bits), ASA (1 bit), PD (2 bits),
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ACH (10 bits), and KNN (20 bits). Using 3AA as example, the length of a feature vector
for a given sequence segment is 7× (1+1+20+3+1+2+10+20) = 174. The small numbers
of features for training might be the major reason to lower the prediction performance for
3, 5, and 7AA. Under current conditions, 19AA is the most accommodative option, and
hence, 19AA is used for the actual search of unknown proteins.
Each segment lengths, i.e., 3AA, 5AA, 7AA, …, 19, 21, and 23 AA, showed the
specific optimized parameter sets (Table 4.1). With the five-fold cross-validation, the
statistical evaluation was obtained and it is also listed in Table 4.1. The predictions for 3,
5, or 7AA length show very low performance. The reason may be the fact that short
segments enclosing epitopic residue hardly provide enough information for classification.
The best prediction is based on 19AA segment training dataset, and 17AA yields close
prediction performance based on the F-measure. Furthermore, with longer segments as
21AA and 23AA, the statistical evaluation showed worse prediction performance than
19AA and 17AA (shown in Table 4.1). The influence of segment lengths on the
prediction of key epitopic residue is similar to what we observed in sliding-window
lengths on linear B-cell epitopes. For our previous tool, SVMTriP, the prediction on
20AA is better than that on the shorter epitope lengths (16).

Table 4.1 Statistical Evaluation of SVMKER with Different Lengths
Segment
c
g
p
Sen
Pre
F
3AA
0.25
0.01 0.0625 0.240 0.275 0.256
5AA
0.25 0.001 0.125 0.232 0.270 0.250
7AA
0.25 0.001 0.125 0.267 0.315 0.289
9AA
0.125 0.0001 0.25 0.335 0.389 0.360
11AA
0.25 0.001 0.125 0.387 0.445 0.413
13AA
0.125 0.0001 0.125 0.468 0.434 0.450
15AA
0.125 0.0001 0.25 0.522 0.483 0.502
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17AA
19AA
21AA
23AA

0.125 0.001
0.125 0.001
0.125 0.0001
0.125 0.0001

0.25
0.25
0.125
0.25

0.572
0.595
0.469
0.442

0.535
0.522
0.481
0.493

0.553
0.556
0.475
0.466

We also compared SVMKER with our two conformational B-cell epitope
prediction tools, EPCES (17) and EPSVR (18). The ROC curves of the three tools are
shown in Figure 4.3 using a length of 19AA. EPCES shows the best prediction
performance, EPSVR the second, and SVMKER the third. The AUC scores for EPCES,
EPSVR and SVMKER are 0.632, 0.582, and 0.549, respectively. The fact that EPCES
received a higher AUC score may be from different test dataset usage. It is in accordance
with the facts that both EPCES and EPSVR are 3D structure-level tools while SVMKER
is based only on protein sequences. All structural level information of a given antigen is
known for EPCES and EPSVR. For EPCES and EPSVR, only surface residues are
considered for prediction. However, SVMKER needs to predict epitopic residues from all
amino acids of a given antigen.
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Figure 4.3 ROC curves for EPCES, EPSVR, and SVMKER throughout five-fold
cross-validation. The area under each ROC curve (AUC) is 0.632, 0.582, and 0.549,
respectively.

4. Discussions
Compared with conformational B-cell epitope tools, SVMKER may possess more
potential for the study of epitopes. For example, although EPCES and EPSVR have better
performance than SVMKER, both require 3D structures of antigens, which greatly limit
their applicability. After all, only a very small proportion of antigens have solved 3D
structures. The determination of protein 3D structures using X-ray diffraction or nuclear
magnetic resonance spectroscopy is time- and fund-consuming. SVMKER requires only
a simple input, i.e., the amino acid sequence of protein candidate, and therefore, it is
more practical for the immunologists. SVMKER has much wider applicability without
the knowledge of 3D structure of protein candidates. Moreover, our comparison shows
that the performance of SVMKER is close to that of EPSVR. Therefore, in despite of the
room for accuracy improvement, as a sequence-level tool, SVMKER may be very useful
in epitopic residue search as a preliminary filter for subsequent experimental design.
SVMKER may not have yet reached the most optimal model. One of the reasons
is the optimization of attributes. The eight attributes mentioned above are usually applied
to predicting binding patterns and motifs. Note that some attributes are dependent to
others. For example, PSSM is often a pre-condition considered in the prediction tool of
protein secondary structure (9). PSSM and SS thus require to be treated as associated
indices if they are both considered in SVMKER. Another issue is the normalization of
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multiple attributes. In the current version of SVMKER, all the attributes have been
normalized into the range of [0, 1]. To improve SVMKER, we will add more attributes
into further consideration. The dependence and normalization of these attributes must be
kept in mind.
We calculated the weight scores of eight attributes in the 19AA optimized model.
The weight scores are calculated by the formula w =∑ αi xi. Here α is dual representation
of the decision boundary; and xi (i=0, 1, 2…n) is vector described in the SVM model.
Both αi and xi are available in the model file. After normalizing weight scores of eight
attributes, we illustrated their weight scores in the optimal model in Figure 4.4. Among
these eight attributes, PSSM has the largest weight score (0.218) while PD is the least
(0.049). That means that PD (the protein disorder feature) only weakly contributes to the
determination of the SVMKER optimized model. The reason could be because of the low
performance of the protein disorder prediction tool that we used. Considering the high
weight scores of PSSM, SS, and KNN, the sequence similarity is still the major factor to
determine the boundary between epitopic residue and non-epitopic residue.

Figure 4.4 The Weight Scores of Eight attributes in 19AA optimal model.

93
Another way to improve SVMKER comes from the update of the training dataset.
In the current version of SVMKER, we only applied the 3D structures of the antigenantibody complex deposited in the PDB database by June 2012. The 3D protein structures
of antigen-antibody complex may precisely provide epitopic residues but the limited
number of available 3D structures constraints the size of the training dataset. More
resource should come from the IEDB database. By the end of 2013, there are more than
50K B-cell epitopes reported in IEDB database. For most epitope entries, the
corresponding binding sites or epitopic residues are recorded or suggested. Some of
epitopic residues were determined by the determination of protein structure or point
mutation experiments. However, most of epitopic residues in IEDB are still hypothetical
from prediction tool and not suitable for training dataset. Obviously, our model cannot be
simply based on these hypothetical epitopic residues since they are predicted and contains
many false positives. It is necessary to carefully check and filter by excluding those
hypothetical epitopic residues in IEDB before they are added to the training dataset. We
believe that the SVMKER performance will be improved when more known epitopic
residues are used to optimize the model.
5. Conclusions
In this chapter, we developed a new tool, SVMKER, to predict epitopic residues
in antigens. The determination of epitopic residues greatly benefits the application of Bcell epitope, such as vaccine design. It can act as the pre-condition for point mutation
experiments on the validation of antigen. The current version of SVMKER reaches a
precision of 59.5% and a sensitivity of 52.2% using five-fold cross-validation. In further
evaluation, we compared SVMKER and EPCES and EPSVR. The AUC score of the
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three tools is 0.549, 0.632, and 0.582, respectively. SVMKER shows a close prediction
performance with EPSVR. Considering its significant advantage as a sequence-level tool,
SVMKER meets much broader needs than EPCES and EPSVR, which are structure-level
tools. We will keep improving SVMKER through further optimization of the attributes
and the continuous enrichment of the training dataset using the IEDB database. All of
optimal models, datasets, and online tool will be released for public usage in the future.
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CHAPTER FIVE: SUMMARY AND FUTURE WORK
1. Summary
In this dissertation, we investigated several computational methods to identify the
antigenic epitopes of protein candidate. First, a new linear B-cell epitope prediction tool
SVMTriP was developed based on the combination of tri-peptide similarity and their
propensity (1). Being compared with other linear B-cell epitope prediction tools, such as
BCPred (2) and AAP (3), SVMTriP showed a better prediction performance with AUC
score as 0.702 (BCPred: 0.667; AAP:0.667). Then, we developed a conformational B-cell
epitope prediction tool called EPSVR and a meta server, EPmeta (4). EPSVR was
developed based on six attributes with Super Vector Regression. EPmeta integrated
multiple single servers, such as DiscoTope (5), PEPITO (6), SEPPA (7), EPITOPIA (8),
EPCES (9), and EPSVR (4), to find a consensus result. The statistical evaluation based
on an independent test dataset showed that EPSVR has the AUC score as 0.597 and
EPmeta as 0.638. The third tool that we developed is SVMKER that can predict epitopic
residues of an antigen sequence. To our knowledge, SVMKER currently is the first
prediction tool of epitopic residues using protein sequence as input. These tools we
developed provide more choices for immunologists to identify the antigenicity of protein
candidate in a quick and cheap way.

1.1 Linear Epitope Prediction
Currently, Users can access SVMTriP by http://sysbio.unl.edu/SVMTriP.
Generally, it takes 20-30 minutes to complete the prediction process for a protein
sequence with a length of 200 AA. If any linear B-cell epitopes are found, they will be
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listed with their scores and locations on the original protein sequence. Users can select
different epitope lengths, from 10AA to 20AA, for their specific cases. In addition, the
training dataset collected from IEDB (10) in SVMTriP is also shared online
(http://sysbio.unl.edu/SVMTriP/Download). These dataset may benefit other B-cell
prediction groups as references to develop new tools.
Since May 12th 2012 when the online server was set up, SVMTriP has been
visited more than 17,000 times, and more than 26,000 jobs were submitted for prediction.
Moreover, we also helped other research groups to predict 12205 protein candidates by
offline operation of SVMTriP.
The application of SVMTriP helps immunologists to quickly narrow the range of
protein candidates. A real case was reported from Dr. Yurij Innov‟s group, Department of
Cancer Genetics, Roswell Park Cancer Institute, NY (private communications). In their
investigation, two non-redundant linear epitopes on the human PAP protein were
discovered by their experiment. One of these two linear epitopes was successfully
predicted by SVMTriP. Other applications of SVMTriP were reported as well, such as
meta-analysis of IgE-binding allergen epitopes (11) and prediction of IL4 Inducing
Peptides (12).

1.2 Conformational Epitope Prediction
We also constructed the online servers for EPSVR (http://sysbio.unl.edu/EPSVR)
and EPmeta (http://sysbio.unl.edu/EPmeta) in 2010. EPSVR requires an input of 3D
structure of protein candidate when submitting a query. The average running time for
EPSVR is 10-20 minutes. Same as EPSVR, EPmeta requires 3D structure of protein
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when opening a new query. Usually, EPmeta requires much longer time that EPSVR
because it needs to get the prediction results from all single servers, and then integrate
into a consensus result. The statistics showed the average running time for a job is 1.5-2
hours.
The development of EPSVR and EPmeta give rise of new members for the very
limited set of available conformational B-cell epitope prediction tools. EPSVR has been
applied to the epitope prediction by many other groups. For example, a read case came
from the identification of epitopes on D8 antigen (13). The prediction of D8 antigen
using EPSVR generated 13 potential epitopic residues. After experimental validation by
site-directed mutations, 6 of 13 variants indeed showed a significant drop in antibodyantigen interaction (13).
More antigen-antibody complex structures may increase the prediction
performance for EPSVR. When we released EPSVR in 2010, only 98 antibody-antigen
complex 3D structures were involved into the training of model. In the past four years,
more and more antibody-antigen complex 3D structures were released. According to
IEDB records, till June 2014, there were 591 antibody-antigen complex 3D structures
reported in PDB database (14). Hence, it is possible to update the training dataset for
EPSVR.

1.3 Epitopic Residue Prediction
Currently, the SVMKER approaches our preliminary requirement but still needs a
further improvement. SVMKER reached a precision of 59.5% and a sensitivity of 52.2%.
The five-fold cross-validation process showed the AUC value of SVMKER was 0.549,
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which was lower than EPCES (0.632) and EPSVR (0.582). Considering the input of
SVMKER was protein residue sequence while that of EPCES and EPSVR was protein
3D structure, SVMKER is more valuable for real studies because most proteins do not
have known 3D structures yet.
The improvement of SVMKER is under our consideration. A possible way is to
find more known epitopic residues and then increase the size of training dataset. Another
strategy is to optimize the vector features of SVMKER model. By determining optimal
weights of vector features, SVMKER is expected to show a higher AUC score.

2. Future Work
2.1 Importance of Food Allergen Prediction
We will extend the epitope prediction tools that we developed to food allergen
prediction. In chapter one, various types of B-cell antibodies, including IgE, which is
mainly involved in allergy (15), were described. For atopic people, a specific allergen
elicits T helper lymphocyte type 2 (Th2) responses (16), and leads to synthesis of
allergen-specific IgE antibodies, which bind to mast cells and basophils. Further exposure
to the antigen may stimulate the release of vasoactive mediators such as histamine and
leukotrienes that cause the symptoms of allergy (17, 18). An IgE can recognize and bind
to the allergen, which leads to a series of allergy-related symptoms. IgEs can bind to
allergens and then stimulate the release of chemical materials, such as histamine and
cytokinase, from the mast cells (19). Hence, allergen should contain at least one IgE
binding site, i.e., epitope.
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Among the variety of allergies troubling human beings, food allergy is one of the
most prevalent diseases affecting almost all races in all geographic locations. Food
allergy is a non-protective immune response triggered by food(s) specific to the affected
individual, such as eggs, cow‟s milk, peanuts, certain tree nuts, soybeans, wheat, and
other complex foods. Allergy is estimated to occur in over 20% of the population in
industrialized countries, primarily as airway allergy, but with between 2-4% of adults and
6-8% of children experiencing allergic symptoms following exposure to specific foods
(20).
The risk of food allergy is increasing synchronously due to the quick development
and application of transgenesis in agriculture. Transgenesis can introduce one or more
exogenous genes, so called transgenes, into a living target organism, such as agricultural
crop or other interesting species. The transgenesis process means new proteins are
expressed in the target organism which potentially increases the risk of food allergen.
Our study on B-cell epitope prediction stimulates our interests on the prediction of
food allergens. Considering the relationship between regular antigen dominant epitopes
and allergens, we proposed to apply our developed tools, such as SVMTriP, EPSVR, and
EPmeta to the prediction of allergens. In the following sections, we will explain our
primary research to assess the probability of an unknown protein as an allergen.
2.2 Design of the Food Allergen Prediction Pipeline
The allergen prediction pipeline includes sequence similarity searching, protein
structure modeling, sequence-level epitope predication, and 3D structure-level epitope
prediction. Figure 5.1 shows the flowchart of the pipeline.
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Figure 5.1: Allergen prediction pipeline using epitope tools

The initial sequence similarity searching is done to broadly search for the allergen
protein candidates including those with even low probabilities to be allergens. The
allergen databases, such as AllergenOnline.org and AFDS, will be used in our pipeline
for this step. For the result of sequence similarity search, the criteria include: 1)
moderately long stretches of amino acid (80 amino acids) with a minimum of 35%
identity and 2) very short stretches (6-8 amino acids) of 100% identity. The search result
matching either of the two criteria will be treated as a potential allergen and therefore
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qualified for the next check. In our preliminarily study, these initial hits from sequence
similarity searching possibly contained rather many false positives, which must be
eliminated by further refinement as discussed in the next sections.
If protein candidate has no available 3D structure, we will apply linear B-cell
epitope prediction tool such as SVMTriP and SVMKER. By SVMTriP, sliding-window
search along the protein sequence is executed to determine the epitopic probability. With
the pre-defined cutoff (the default cutoff is 0.2), once the epitopes are picked up, these
potential antibody-binding sites, usually with 8-20 amino acids, will have another round
of similarity search against allergen databases, such as AllergenOnline.org and AFDS. If
the high similarity hits (>80%) find in allergen databases match the epitopes from
SVMTriP, the protein candidate is thought of one allergen with a high confidence.
If the 3D structure of protein candidate is available, conformational epitope
prediction tools such as EPSVR, EPCES, and EPmeta can be used. If the protein structure
is not available, we will conduct the structural modeling to predict the protein structure
with SPARKS-X, a tool to predict 3D protein structures (28, 30). After the 3D structure is
predicted, conformational B-cell epitope tools will continue the rest of prediction
processing.

2.3 Summary
Our developed B-cell epitope prediction tools are the good supplement for the
prediction of allergens. Considering the very limited resource of known allergens and
even more limited knowledge regarding IgE-binding sites on these allergens, it is quite
difficult to apply any machine learning technologies to the classification and
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identification of IgE binding site on proteins. Currently the most common strategy still
relies heavily on the traditional sequence similarity search using FASTA and BLASTP
tools. However, the results from FASTA and BLASTP contain an unsatisfactory level of
false positive rates. In the pipeline we designed, we apply the similarity search method as
well as epitope prediction methods, both linear and conformational, to predict the
potential epitopic sites on a protein candidate. The discovery of antibody epitopes will
increase the confidence level for the allergen prediction. The candidates with low scores
that do not pass the checking point of epitopic sites are eliminated to decrease the false
positive rate from the sequence similarity search.
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